- HIPO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
POS AM Filing
Hippo (HIPO) POS AMProspectus update (post-effective amendment)
Filed: 19 Apr 22, 5:07pm
Delaware | 6770 | 32- 0662604 | ||
(State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
Large accelerated filer | Accelerated filer | ☐ | ||||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Page | ||||
ii | ||||
v | ||||
1 | ||||
8 | ||||
52 | ||||
53 | ||||
54 | ||||
71 | ||||
100 | ||||
106 | ||||
112 | ||||
114 | ||||
123 | ||||
128 | ||||
138 | ||||
139 | ||||
142 | ||||
142 | ||||
142 | ||||
F-1 |
• | “Business Combination” are to the Domestication together with the Merger; |
• | “Bylaws” are to our amended and restated bylaws; |
• | “Cayman Islands Companies Law” are to the Cayman Islands Companies Act (As Revised); |
• | “Certificate of Incorporation” are our amended and restated certificate of incorporation; |
• | “Closing” are to the closing of the Business Combination; |
• | “Continental” are to Continental Stock Transfer & Trust Company; |
• | “DGCL” are to the General Corporation Law of the State of Delaware; |
• | “Domestication” are to the domestication of RTPZ as a corporation incorporated in the State of Delaware; |
• | “Effective Time” are to the effective time of the Merger; |
• | “ESPP” are to the Hippo Holdings Inc. 2021 Employee Stock Purchase Plan; |
• | “Exchange Act” are to the Securities Exchange Act of 1934, as amended; |
• | “Exchange Ratio” are to the quotient obtained by dividing (i) the Aggregate Merger Consideration by (ii) the aggregate fully-diluted number of shares of Hippo Holdings common stock issued and outstanding immediately prior to the First Merger; |
• | “GAAP” are to accounting principles generally accepted in the United States of America; |
• | “Hippo” are to Hippo Holdings Inc. and its consolidated subsidiaries and businesses, including Spinnaker, after the Business Combination; |
• | “Hippo Holdings common stock” are to shares of Hippo Holdings common stock, par value $0.0001 per share; |
• | “Hippo Holdings Inc.” or “Hippo Holdings” are to RTPZ after the Domestication and its name change from Reinvent Technology Partners Z to Hippo Holdings Inc.; |
• | “Hippo Holdings options” are to options to purchase shares of Hippo Holdings common stock; |
• | “Hippo notes” are to the convertible promissory notes issued by Hippo and convertible into shares of Hippo Holdings common stock; |
• | “Incentive Award Plan” are to the Hippo Holdings Inc. 2021 Incentive Award Plan; |
• | “initial public offering” are to RTPZ’s initial public offering that was consummated on November 23, 2020; |
• | “IPO registration statement” are to the Registration Statement on Form S-1 (333-249799) filed by RTPZ in connection with its initial public offering, which became effective on November 18, 2020; |
• | “IRS” are to the U.S. Internal Revenue Service; |
• | “JOBS Act” are to the Jumpstart Our Business Startups Act of 2012; |
• | “Merger” are to the merger of Merger Sub with and into Old Hippo, with Old Hippo surviving the merger as a wholly owned subsidiary of Hippo Holdings; |
• | “Merger Sub” means RTPZ Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of RTPZ prior to the Business Combination, which, as a result of the Merger, merged into Old Hippo; |
• | “NYSE” are to the New York Stock Exchange; |
• | “Old Hippo” are to Hippo Enterprises Inc. prior to the Business Combination, which became a wholly owned subsidiary of Hippo Holdings and later merged into Hippo Holdings as a result of the Business Combination; |
• | “Old Hippo capital stock” are to shares of Old Hippo common stock and Old Hippo preferred stock. |
• | “Old Hippo common stock” are to shares of Old Hippo common stock, par value $0.00001 per share; |
• | “Old Hippo preferred stock” are to the Series A-1 preferred stock, SeriesA-2 preferred stock, Series B preferred stock, SeriesC-1 preferred stock, Series C preferred stock, Series D preferred stock and Series E preferred stock of Old Hippo; |
• | “Old Hippo warrants” are to the warrants to purchase shares of Hippo capital stock outstanding prior to the Effective Time; |
• | “Organizational Documents” are to the Certificate of Incorporation and the Bylaws; |
• | “PIPE Investment” are to the purchase of shares of Hippo Holdings common stock pursuant to the Subscription Agreements; |
• | “PIPE Investors” are to those certain investors participating in the PIPE Investment pursuant to the Subscription Agreements; |
• | “private placement warrants” are to the RTPZ private placement warrants outstanding as of the date of this prospectus and the warrants of Hippo Holdings issued as a matter of law upon the conversion thereof at the time of the Domestication; |
• | “public shares” are to the RTPZ Class A ordinary shares (including those that underlie the units of RTPZ) that were offered and sold by RTPZ in its initial public offering and registered pursuant to the IPO registration statement and the shares of Hippo Holdings common stock issued as a matter of law upon the conversion thereof on the effective date of the Domestication. |
• | “public warrants” are to the redeemable warrants (including those that underlie the units of RTPZ) that were offered and sold by RTPZ in its initial public offering and registered pursuant to the IPO registration statement or the redeemable warrants of Hippo Holdings issued as a matter of law upon the conversion thereof at the time of the Domestication; |
• | “redemption” are to each redemption of public shares for cash pursuant to the Organizational Documents; |
• | “Registration Rights Agreement” are to the Registration Rights Agreement entered into by and among Hippo Holdings, the Sponsor and the other holders of RTPZ Class B ordinary shares, certain former stockholders of Hippo, and Reinvent Capital Fund LP, as amended and modified from time to time; |
• | “RTPZ” are to Reinvent Technology Partners Z prior to its domestication as a corporation in the State of Delaware; |
• | “RTPZ Class A ordinary shares” are to RTPZ’s Class A ordinary shares, par value $0.0001 per share; |
• | “RTPZ Class B ordinary shares” are to RTPZ’s Class B ordinary shares, par value $0.0001 per share; |
• | “RTPZ founder shares” are to the 5,750,000 RTPZ Class B ordinary shares purchased by the Sponsor in a private placement prior to the initial public offering for an aggregate purchase price of $25,000 (or approximately $0.004 per share), and the RTPZ Class A ordinary shares that will be issued upon the conversion thereof; |
• | “Sarbanes-Oxley Act” are to the Sarbanes-Oxley Act of 2002; |
• | “SEC” are to the United States Securities and Exchange Commission; |
• | “Securities Act” are to the Securities Act of 1933, as amended; |
• | “Selling Securityholder” are to the selling securityholders named in this prospectus; |
• | “Spinnaker” are to Spinnaker Insurance Company; |
• | “Sponsor” are to Reinvent Sponsor Z LLC, a Cayman Islands limited liability company; |
• | “Sponsor Agreement” are to that certain Sponsor Agreement, dated March 3, 2021, by and between RTPZ and Hippo, as amended and modified from time to time; |
• | “Sponsor Shares” are to the RTPZ founder shares that were beneficially owned by the Sponsor as of the Domestication. |
• | “Subscription Agreement” are to that certain Sponsor Agreement, dated March 3, 2021, by and between RTPZ and Hippo, as amended and modified from time to time; |
• | “Transaction” are to Old Hippo becoming a wholly owned subsidiary of Hippo Holdings as a result of Merger Sub, a direct wholly owned subsidiary of RTPZ, merging with and into Old Hippo, with Old Hippo surviving as a wholly owned subsidiary of Hippo Holdings; |
• | “Trust Account” are to the trust account established at the consummation of RTPZ’s initial public offering at JPMorgan Chase Bank, N.A. and maintained by Continental, acting as trustee; |
• | “Warrant Agreement” is to the Warrant Agreement, dated as of November 18, 2020, by and between RTPZ and Continental, as warrant agent, as amended; and |
• | “warrants” are to the public warrants and the private placement warrants. |
• | our future results of operations and financial condition and our ability to attain profitability; |
• | our ability to grow our business and, if such growth occurs, to effectively manage such growth; |
• | customer satisfaction and our ability to attract, retain, and expand our customer base; |
• | our ability to maintain and enhance our brand and reputation; |
• | our business strategy, including our diversified distribution strategy and our plans to expand into new markets and new products; |
• | the effects of seasonal trends on our results of operations; |
• | our expectations about our book of business, including our ability to cross-sell and to attain greater value from each customer; |
• | our ability to compete effectively in our industry; |
• | our ability to maintain reinsurance contracts and our near- and long-term strategies and expectations with respect to cession of insurance risk; |
• | our ability to utilize our proprietary technology; |
• | our ability to underwrite risks accurately and charge profitable rates; |
• | our ability to leverage our data, technology and geographic diversity to help manage risk; |
• | our ability to protect our intellectual property; |
• | our ability to expand our product offerings or improve existing ones; |
• | our ability to attract and retain personnel, including our officers and key employees; |
• | potential harm caused by misappropriation of our data and compromises in cybersecurity; |
• | potential harm caused by changes in internet search engines’ methodologies; |
• | our expected use of cash on our balance sheet, our future capital needs and our ability to raise additional capital; |
• | fluctuations in our results of operations and operating metrics; |
• | our ability to receive, process, store, use and share data, and compliance with laws and regulations related to data privacy and data security; |
• | our ability to stay in compliance with laws and regulation that currently apply, or become applicable, to our business both in the United States and internationally; |
• | our inability to predict the lasting impacts of COVID-19 to our business in particular, and the global economy generally; |
• | our public securities’ liquidity and trading; and |
• | other factors detailed in the section titled “ Risk Factors |
• | Hippo Holdings makes policies fast and easy to buy. |
• | Hippo Holdings’ policies are designed for the modern homeowner. |
• | Hippo Holdings has designed a proactive, human approach to claims, enabled by technology. |
• | Hippo Holdings has pioneered what it believes is the most widely adopted Smart Home program in the U.S. industry. |
• | Hippo Holdings proactively helps its customers maintain and protect their homes. |
• | We have a history of net losses and we may not achieve or maintain profitability in the future. |
• | Our success and ability to grow our business depend on retaining and expanding our customer base. If we fail to add new customers or retain current customers, our business, revenue, operating results, and financial condition could be harmed. |
• | The “Hippo” brand may not become as widely known as incumbents’ or other competitors’ brands or the brand may become tarnished. |
• | Denial of claims or our failure to accurately and timely pay claims could materially and adversely affect our business, financial condition, results of operations, and our reputation. |
• | Our limited operating history makes it difficult to evaluate our current business performance, implementation of our business model, and our future prospects. |
• | We may not be able to manage our growth effectively. |
• | Intense competition in the segments of the insurance industry in which we operate could negatively affect current financials and our ability to attain or increase profitability. |
• | Reinsurance may be unavailable, including at current coverage, limits, or pricing, which may limit our ability to write new or renew existing business. Furthermore, reinsurance subjects our insurance company subsidiaries to counterparty credit and performance risk and may not be adequate to protect us against losses, each of which could have a material effect on our results of operations and financial condition. |
• | Failure to maintain our risk-based capital at the required levels could adversely affect the ability of our insurance company subsidiaries to maintain regulatory authority to conduct our business. |
• | Failure to maintain our financial strength ratings could adversely affect the ability of our insurance company subsidiaries to conduct our business as currently conducted. |
• | If we are unable to underwrite risks accurately and charge competitive yet profitable rates to our customers, our business, results of operations, and financial condition will be adversely affected. |
• | Our proprietary technology, which relies on third-party data, may not operate properly or as we expect it to. |
• | Our technology platform may not operate properly or as we expect it to operate. |
• | Our future success depends on our ability to continue to develop and implement our technology and to maintain the confidentiality of this technology. |
• | New legislation or legal requirements may affect how we communicate with our customers, which could have a material adverse effect on our business model, financial condition, and results of operations. |
• | We rely on external data and our digital platform to collect and evaluate information that we utilize in producing, pricing, and underwriting our insurance policies (in accordance with the rates, rules, and forms filed with our regulators, where required), managing claims and customer support, and improving business processes. Any legal or regulatory requirements that might restrict our ability to collect or utilize this data or our digital platform, or an outage by a data vendor, could thus materially and adversely affect our business, financial condition, results of operations, and prospects. |
• | We depend on search engines, content based online advertising, and other online sources to attract consumers to our website, which may be affected by third-party interference beyond our control. In addition, our producer and partner distribution channels are significant sources of new customers and could be impacted by third-party interference or other factors. As we grow, our customer acquisition costs may increase. |
• | We may require additional capital to grow our business, which may not be available on terms acceptable to us or at all. |
• | Interruptions or delays in the services provided by our providers of third-party technology platforms or our internet service providers could impair the operability of our website and may cause our business to suffer. |
• | Security incidents or real or perceived errors, failures, or bugs in our systems or website could impair our operations, result in loss of customers’ personal information, damage our reputation and brand, and harm our business and operating results. |
• | Misconduct or fraudulent acts by employees, agents, claims vendors, or third parties may expose us to financial loss, disruption of business, regulatory assessments, and reputational harm. |
• | Our success depends, in part, on our ability to establish and maintain relationships with quality and trustworthy service professionals. |
• | We may be unable to prevent, monitor, or detect fraudulent activity, including policy acquisitions or payments of claims that are fraudulent in nature. |
• | We are periodically subject to examinations by our primary state insurance regulators, which could result in adverse examination findings and necessitate remedial actions. |
• | We are subject to laws and regulations concerning our collection, processing, storage, sharing, disclosure, and use of customer information and other sensitive data, and our actual or perceived (or alleged) failure to comply with data privacy and security laws and regulations could damage our reputation and brand and harm our business and operating results. |
• | We employ third-party licensed data, software, technologies, and intellectual property for use in our business, and the inability to maintain or use these licenses, or errors or defects in the data, software, technologies, and intellectual property we license could result in increased costs or reduced service levels, which would adversely affect our business, financial condition, and results of operations. |
• | Failure to protect or enforce our intellectual property rights could harm our business, results of operations, and financial condition. |
• | Our services utilize third-party open source software components, which may pose particular risks to our proprietary software, technologies, products, and services in a manner that could negatively affect our business. |
• | We may be unable to prevent or address the misappropriation of our data. |
• | We rely on the experience and expertise of our founder, senior management team, highly-specialized insurance experts, key technical employees, and other highly skilled personnel. |
• | If our customers were to claim that the policies they purchased failed to provide adequate or appropriate coverage, we could face claims that could harm our business, results of operations, and financial condition. |
• | We may become subject to claims under Israeli law for remuneration or royalties for assigned invention rights by our Israel-based contractors or employees, which could result in litigation and adversely affect our business. |
• | Our company culture has contributed to our success and if we cannot maintain this culture as we grow, our business could be harmed. |
• | Our exposure to loss activity and regulation may be greater in states where we currently have more of our customers or where we are domiciled. |
• | Our product development cycles are complex and subject to regulatory approval, and we may incur significant expenses before we generate revenues, if any, from new or expansion of or changes to existing products. |
• | Our success depends upon the continued growth in the use of the internet for purchasing of insurance products. |
• | New lines of business or new products and services may subject us to additional risks. |
• | Litigation and legal proceedings filed by or against us and our subsidiaries, key vendors, joint ventures, or investments could have a material adverse effect on our business, results of operations, and financial condition. |
• | Claims by others that we infringed their proprietary technology or other intellectual property rights could result in litigation which is expensive to support, and if resolved adversely, could harm our business. |
• | If we are unable to make acquisitions and investments, or if we are unable to successfully integrate them into our business, our business, results of operations, and financial condition could be adversely affected. |
• | We may not be able to utilize a portion of our net operating loss carryforwards (“NOLs”) to offset future taxable income, which could adversely affect our net income and cash flows. |
• | Our expansion strategy will subject us to additional costs and risks and our plans may not be successful. |
• | We are subject to payment processing risk. |
• | We are exposed to risk through our captive reinsurer, RH Solutions Insurance Ltd., which takes a share of the risk underwritten of affiliated and non-affiliated insurance carriers for business written through a managing general agent (“MGA”). |
• | We are exposed to risk through our admitted and non-admitted insurance carriers, which underwrite insurance on behalf of our MGA and othernon-affiliated general agents and managing general agents. |
• | The insurance business, including the market for homeowners’ insurance, is historically cyclical in nature, and we may experience periods with excess underwriting capacity and unfavorable premium rates, which could adversely affect our business. |
• | Our actual incurred losses may be greater than our loss and loss adjustment expense reserves, which could have a material adverse effect on our financial condition and results of operations. |
• | We are subject to extensive insurance industry regulations. |
• | A regulatory environment that requires rate increases and product forms to be approved and that can dictate underwriting practices and mandate participation in loss sharing arrangements may adversely affect our results of operations and financial condition. |
• | State insurance regulators impose additional reporting requirements regarding enterprise risk on insurance holding company systems, with which we must comply as an insurance holding company. |
• | The increasing adoption by states of cybersecurity regulations could impose additional compliance burdens on us and expose us to additional liability. |
• | The COVID-19 pandemic has caused disruption to our operations and may continue to negatively impact our business, key metrics, or results of operations in numerous ways that remain unpredictable. |
• | Severe weather events and other catastrophes, including the effects of climate change, global pandemics, and terrorism, are inherently unpredictable and may have a material adverse effect on our financial results and financial condition. |
• | We expect our results of operations to fluctuate on a quarterly and annual basis. In addition, our operating results and operating metrics are subject to seasonality and volatility, which could result in fluctuations in our quarterly revenues and operating results or in perceptions of our business prospects. |
• | An overall decline in economic activity could have a material adverse effect on the financial condition and results of operations of our business. |
• | Our results of operations and financial condition may be adversely affected due to limitations in the analytical models used to assess and predict our exposure to catastrophe losses. |
• | Our insurance company subsidiaries are subject to minimum capital and surplus requirements, and failure to meet these requirements could subject us to regulatory action. |
• | Our insurance company subsidiaries are subject to assessments and other surcharges from state guaranty funds and mandatory state insurance facilities, which may reduce our profitability. |
• | Performance of our investment portfolio is subject to a variety of investment risks that may adversely affect our financial results. |
• | Unexpected changes in the interpretation of our coverage or provisions, including loss limitations and exclusions in our policies, could have a material adverse effect on our financial condition and results of operations. |
• | There may not be an active trading market for our common stock, which may make it difficult to sell shares of our common stock, and there can be no assurance that we will be able to comply with the continued listing standards of such exchange. |
• | The market price of our common stock and warrants may be highly volatile, which could cause the value of your investment to decline. |
• | If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our markets, or if they adversely change their recommendations or publish negative reports regarding our business or our stock, our stock price and trading volume could materially decline. |
• | Some provisions of our Organizational Documents Certificate of Incorporation and Bylaws and Delaware law may have anti-takeover effects that could discourage an acquisition of us by others, even if an acquisition would be beneficial to our stockholders, and they may prevent attempts by our stockholders to replace or remove our current management. |
• | Applicable insurance laws may make it difficult to effect a change of control. |
• | Our Certificate of Incorporation designates the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us. |
• | Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us. |
• | Taking advantage of the reduced disclosure requirements applicable to “emerging growth companies” may make our common stock less attractive to investors. |
• | Failure to establish and maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and stock price. |
• | We depend on the ability of our subsidiaries to transfer funds to us to meet our obligations, and our insurance company subsidiaries’ ability to pay dividends to us is restricted by law. |
• | We do not currently expect to pay any cash dividends. |
• | The requirements of being a public company, including compliance with the reporting requirements of the Exchange Act, the requirements of the Sarbanes-Oxley Act and the Dodd-Frank Act, and the listing standards of NYSE, may strain our resources, increase our costs, and divert management’s attention, and we may be unable to comply with these requirements in a timely or cost-effective manner. In addition, key members of our management team have limited experience managing a public company. |
• | Sales of a substantial number of shares of our common stock by our existing stockholders in the public market could cause our stock price to fall. |
• | Warrants are exercisable for Hippo Holdings common stock, which increases the number of shares eligible for future resale in the public market and could result in dilution to our stockholders. |
• | We may redeem the unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless. |
• | Our warrants are accounted for as liabilities and the changes in value of our warrants could have a material effect on our financial results. |
• | we fail to effectively use search engines, social media platforms, content-based online advertising, and other online sources for generating traffic to our website; |
• | potential customers in a particular marketplace or more generally do not meet our underwriting guidelines; |
• | our products are not competitive in terms of customer experience, pricing, or insurance coverage options; |
• | our competitors mimic our digital platform or develop other innovative services, causing current and potential customers to purchase their insurance products instead of our products; |
• | we lose customers to new market entrants and/or existing competitors; |
• | we do not obtain regulatory approvals necessary for expansion into new markets or in relation to our products (such as line, form, underwriting, and rating approvals) or such approvals contain conditions that impose restrictions on our operations (such as limitations on growth); |
• | our digital platform experiences disruptions; |
• | we suffer reputational harm to our brand resulting from negative publicity, whether accurate or inaccurate; |
• | we fail to expand geographically; |
• | we fail to offer new and competitive products, to provide effective updates to our existing products or to keep pace with technological improvements in our industry; |
• | we are unable to maintain traditional retail agent relationships; |
• | customers have difficulty installing, updating or otherwise accessing our website on mobile devices or web browsers as a result of actions by us or third parties; |
• | customers are unable or unwilling to adopt or embrace new technology; |
• | technical or other problems frustrate the customer experience, particularly if those problems prevent us from generating quotes or paying claims in a fast and reliable manner; or |
• | we are unable to address customer concerns regarding the content, data privacy, and security generally or for our digital platform specifically. |
• | changes in the financial profile of one of our insurance companies; |
• | changes in a rating agency’s determination of the amount of capital required to maintain a particular rating; or |
• | increases in the perceived risk of our investment portfolio, a reduced confidence in management or our business strategy, or other considerations that may or may not be under our control. |
• | collect and properly and accurately analyze a substantial volume of data from our customers; |
• | develop, test, and apply appropriate actuarial projections and rating formulas; |
• | review and evaluate competitive product offerings and pricing dynamics; |
• | closely monitor and timely recognize changes in trends; and |
• | project both frequency and severity of our customers’ losses with reasonable accuracy. |
• | insufficient, inaccurate, or unreliable data; |
• | incorrect or incomplete analysis of available data; |
• | uncertainties generally inherent in estimates and assumptions; |
• | our failure to establish or implement appropriate actuarial projections and rating formulas or other pricing methodologies; |
• | incorrect or incomplete analysis of the competitive environment; |
• | regulatory constraints on rate increases or coverage limitations; |
• | our failure to accurately estimate investment yields and the duration of our liability for loss and loss adjustment expenses; and |
• | unanticipated litigation, court decisions, legislative or regulatory actions, or changes to the existing regulatory landscape. |
• | failure to identify, attract, reward and retain people in leadership positions in our organization who share and further our culture, values, and mission; |
• | the increasing size and geographic diversity of our workforce and our ability to promote a uniform and consistent culture across all our offices and employees; |
• | competitive pressures to move in directions that may divert us from our mission, vision, and values; |
• | the continued challenges of a rapidly evolving industry; and |
• | the increasing need to develop expertise in new areas of business that affect us. |
• | intense competition for suitable acquisition targets, which could increase prices and adversely affect our ability to consummate deals on favorable or acceptable terms; |
• | failure or material delay in closing a transaction, including as a result of regulatory review and approvals; |
• | inadequacy of reserves for losses and loss expenses; |
• | quality of their data and underwriting processes; |
• | conditions imposed by regulatory agencies that make the realization of cost-savings through integration of operations more difficult; |
• | difficulties in obtaining regulatory approvals on our ability to be an acquirer; |
• | a need for additional capital that was not anticipated at the time of the acquisition; |
• | transaction-related lawsuits or claims; |
• | difficulties in integrating the technologies, operations, existing contracts, and personnel of an acquired company; |
• | difficulties in retaining key employees or business partners of an acquired company; |
• | diversion of financial and management resources from existing operations or alternative acquisition opportunities; |
• | failure to realize the anticipated benefits or synergies of a transaction; |
• | failure to identify the problems, liabilities, or other shortcomings or challenges of an acquired company or technology, including issues related to intellectual property, regulatory compliance practices, litigation, accounting practices, or employee or user issues; |
• | risks that regulatory bodies may enact new laws or promulgate new regulations that are adverse to an acquired company or business; |
• | theft of our trade secrets or confidential information that we share with potential acquisition candidates; |
• | risk that an acquired company or investment in new offerings cannibalizes a portion of our existing business; |
• | adverse market reaction to an acquisition; |
• | significant attention from management and disruption to our business; and |
• | potential dilution in value to our stockholders. |
• | barriers to obtaining the required government approvals, licenses, or other authorizations, including seasoning or other limitations imposed by a state; |
• | failures in identifying and entering into joint ventures with strategic partners or entering into joint ventures that do not produce the desired results; |
• | challenges in, and the cost of, complying with various laws and regulatory standards, including with respect to the insurance business and insurance distribution, capital and outsourcing requirements, data privacy, tax and regulatory restrictions; |
• | competition from incumbents that already own market share, better understand the market, may market and operate more effectively, and may enjoy greater affinity or awareness; and |
• | differing demand dynamics, which may make our product offerings less successful. |
• | the occurrence of severe weather conditions and other catastrophes; |
• | our operating and financial performance, quarterly or annual earnings relative to similar companies; |
• | publication of research reports or news stories about us, our competitors or our industry, or positive or negative recommendations, or withdrawal of research coverage by securities analysts; |
• | the public’s reaction to our press releases, our other public announcements and our filings with the SEC; |
• | announcements by us or our competitors of acquisitions, business plans or commercial relationships; |
• | any major change in our board of directors or senior management, including the departure of our CEO; |
• | sales of our common stock by us, our directors, executive officers, principal shareholders, our CEO and/or the PIPE Investors, or expectations of such sales given the release of shares from applicable lock-ups over time; |
• | adverse market reaction to any indebtedness we may incur or securities we may issue in the future; |
• | short sales, hedging and other derivative transactions in our common stock; |
• | exposure to capital market risks related to changes in interest rates, realized investment losses, credit spreads, equity prices, foreign exchange rates and performance of insurance-linked investments; |
• | our creditworthiness, financial condition, performance, and prospects; |
• | changes in the fair values of our financial instruments (including certain warrants assumed in connection with the Business Combination); |
• | our dividend policy and whether dividends on our common stock have been, and are likely to be, declared and paid from time to time; |
• | perceptions of the investment opportunity associated with our common stock relative to other investment alternatives; |
• | regulatory or legal developments; |
• | changes in general market, economic, and political conditions; |
• | conditions or trends in our industry, geographies, or customers; |
• | changes in accounting standards, policies, guidance, interpretations or principles; |
• | the impact of the COVID-19 pandemic on our management, employees, partners, customers, operating results, and the general market and economy; and |
• | threatened or actual litigation or government investigations. |
• | our board of directors is classified into three classes of directors with staggered three-year terms, and directors are only able to be removed from office for cause; |
• | nothing in our Certificate of Incorporation precludes future issuances without stockholder approval of the authorized but unissued shares of our common stock; |
• | advance notice procedures apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders; |
• | our stockholders are only able to take action at a meeting of stockholders and not by written consent; |
• | only our chairman of the board of directors, our chief executive officer, our president, or a majority of the board of directors are authorized to call a special meeting of stockholders; |
• | no provision in our Certificate of Incorporation or Bylaws provides for cumulative voting, which limits the ability of minority stockholders to elect director candidates; |
• | certain amendments to our Certificate of Incorporation requires the approval of two-thirds of the then outstanding voting power of our capital stock; |
• | our Bylaws provide that the affirmative vote of two-thirds of the then-outstanding voting power of our capital stock, voting as a single class, is required for stockholders to amend or adopt any provision of our Bylaws; |
• | our Certificate of Incorporation authorizes undesignated preferred stock, the terms of which may be established and shares of which may be issued, without the approval of the holders of our capital stock; and |
• | certain litigation against us can only be brought in Delaware. |
• | the business combination or transaction which resulted in the stockholder becoming an interested stockholder was approved by the board of directors prior to the time that the stockholder became an interested stockholder; |
• | upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding shares owned by directors who are also officers of the corporation and shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or |
• | at or subsequent to the time the stockholder became an interested stockholder, the business combination was approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder. |
• | any breach of the director’s duty of loyalty to the corporation or its stockholders; |
• | any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |
• | unlawful payments of dividends or unlawful stock repurchases or redemptions; or |
• | any transaction from which the director derived an improper personal benefit. |
• | be required to have only two years of audited financial statements and only two years of related Management’s Discussion and Analysis of Financial Condition and Results of Operations disclosure; |
• | be exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that its independent registered public accounting firm provide an attestation report on the effectiveness of its internal control over financial reporting; |
• | be exempt from the “say on pay” and “say on golden parachute” advisory vote requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”); and |
• | be exempt from certain disclosure requirements of the Dodd-Frank Act relating to compensation of its executive officers and be permitted to omit the detailed compensation discussion and analysis from proxy statements and reports filed under the Exchange Act. |
• | We make Hippo policies fast and easy to buy |
• | Our policies are designed for the modern homeowner |
• | We have designed a proactive, human approach to claims, enabled by technology |
• | We have pioneered what we believe is the most widely adopted Smart Home program in the industry |
• | We proactively help our customers maintain and protect their homes |
• | Significant initial capital requirements to support insurance risk, challenges finding cost-effective reinsurance without an underwriting track record, expensive off-the-shelf |
• | Complicated and fragmented regulatory landscape with a unique set of rules from each state |
• | Significant resource investment in tech and infrastructure to access, collect and validate insurance-related data, in addition to the development of multiple customized APIs |
• | Difficulty accessing distribution networks, built upon a legacy, agent-based distribution, or resource-intensive process of creating and scaling new, alternative customer acquisition channels |
• | We make insurance easy to buy: |
• | We designed our policies for the modern homeowner: |
• | We crafted a proactive, tech-enabled claims experience, focused on a live, white-glove approach: |
• | Proactive, technology-enabled approach : We aspire to be there for our customers as soon as the need arises, if possible before they even reach out to us for support. We use live data to help identify major events like fires or storms. When we suspect that our customers’ homes may be impacted, our Claims Concierge team reaches out proactively to help ensure the safety of our customer, their families and their homes. We firmly believe in prioritizing the well-being of our customers and addressing damage to the home quickly, hopefully before things deteriorate or repair costs escalate. If we are effective, customers benefit from superior service in resolving claims, and we gain from better insurance outcomes by mitigating costs and increased customer loyalty. |
• | Depending on the claim, our Claims Concierge team may use remote (virtual) inspection technology to expedite the claims handling process and, if possible, complete a claim remotely. When a specialist needs to visit the home, we leverage a network of vetted partners whom we work to quickly deploy, seeking to offer our customers full resolution as opposed to just an inspection. This network of trusted partners allows us to save on inspection costs when these partners also perform the work to resolve the issue, benefit from economies of scale in material purchases, and work to ensure quality repair work which reduces the probability of a repeat claim. This approach is designed to align everyone’s incentives and works to drive the best outcome and as fast a resolution as possible. |
• | Human attention from live Claims Concierges : We believe that a customer calling about damage to their home, often a very complicated and stressful situation, needs to speak to a human who can |
be relied upon for help. Our Claims Concierge team eliminates the often-inefficient use of bots or automation, as well as other burdensome processes. Our claims professionals are experienced in both claims handling and customer service. Once a claim is submitted, a Claims Concierge is assigned to the claim and focuses first on ensuring customer safety and alleviating stress. We seek to have the same Claims Concierge remain the key point of contact for the customer throughout the life of the claim. |
• | We employ continuous risk reevaluation and underwriting: |
• | We deploy what we believe is the most widely adopted Smart Home program in the U.S. home insurance space: |
• | We help customers maintain their homes: in-home services. Moreover, Hippo Home Care has been building a proactive home maintenance offering: homeowners can consult with home professionals about specific home care and maintenance questions, or opt for broader virtual checkups focused on key systems around the home. |
• | Direct to consumer: |
• | Insurance partners (agents / producers): |
efficiency and accuracy that our online, direct-to-consumer |
• | Non-insurance partners: |
• | Home builders - we developed an insurance policy for new home construction, as well as a technology product that integrates with builders’ sales systems. These integrations allow us to offer the builder’s customers a simple, personalized insurance product precisely when their customers are in the market for a policy. These policies are heavily tailored to the customer’s property and can be easily purchased online or through our partner agency. Through these partnerships, we are able to access positively selected properties with a fundamentally better risk profile than those associated with older homes. The result is a potentially smoother home purchase experience and higher customer satisfaction for our builder partners. |
• | Smart home providers - we have been developing proprietary integrations with the leading providers of smart home and security systems to offer their customers better home insurance coverage with meaningful premium discounts. Moreover, these benefits are also available to our partners’ customers if they purchase insurance from Hippo. |
• | Offering a fast and accurate online purchase flow that meets modern consumers’ expectations |
• | Integrating smart home activation status into our policy management system |
• | Quickly deploying rate changes in any state or region upon regulatory approval |
• | Creating sophisticated feedback loops between internal teams to ensure cross-pollination (for example, fast underwriting improvements based on claims insights) |
• | Developing proprietary, channel-specific technology to integrate Hippo’s offerings into partners’ platforms and streamlining their go-to-market |
• | The majority of eligible customers opt into the program |
• | The vast majority of the customers opting into the program activate their kits |
• | Customers who keep their kits active receive meaningful premium discounts |
• | Rapid growth across diverse channels |
• | Risk prevention and proactive home protection |
• | Better experiences throughout the customer journey |
• | Our agile development teams are able to design, deliver and iterate to build product features our customers and partners desire. We have built a flexible and adaptable software architecture and engineering teams to effectively innovate and implement new ideas. This is combined with an agile, iterative approach to experimentation and analytics, working to make sure that we continuously improve our knowledge of what customers want. |
• | Our underlying software architecture and platform are designed to support future expansion and growth. We are creating data models, algorithms, learning engines, knowledge graphs and cloud platforms that are all intended to support a future set of goals - more ambitious partnerships, wider distribution channels, and larger numbers of customers. By anticipating future growth with a blueprint of technology capabilities and technical platforms, we are proactively preparing for the next step-change in our company’s growth trajectory. |
• | We are keeping the pace of innovation high by investing in research and development of underlying technologies and capabilities that seek to change how the market operates in protecting homeowners. We launch tests with partners, look at new and proprietary data sources, offer additional virtual and in-home services, expand the boundaries of expectations on preventative measures, and try out new techniques for customer support and service. All of these are part of our innovation culture and supported by the technology infrastructure to build, experiment, measure, iterate. |
• | We write and place home insurance and other insurance products from our agencies that have so far been largely unaffected by COVID-19. |
• | Our systems are entirely cloud-based and accessible to our teams from any browser anywhere in the world. Customers’ phone calls are routed to our team’s laptops and answered and logged from wherever they happen to be. Internal communication has been via email, Slack, and Zoom since our founding. Our teams are able to access systems, support customers and collaborate with each other from anywhere, much as they did before the pandemic. |
• | Our customers’ experience has also been largely unaffected by COVID-19 related disruptions. |
• | We have initiated virtual inspections for our underwriting requirements and claims processing to keep our employees, agents, policy holders and potential policy holders safe. We are closely monitoring the impact of the COVID-19 pandemic and related economic effects on all aspects of our business, including how it will impact our production, loss ratios, recoverability of premium, our operations, and the fair value of our investment portfolio. |
• | Our growth strategy is centered around accelerating our existing position in markets that we already serve by increasing our direct-to-consumer |
• | In addition to efforts in states where we are currently selling insurance, we also expect to drive growth by expanding into new markets across the United States and by continuing to develop new strategic partnerships with key players involved in the real estate transaction ecosystem. |
• | Finally, we plan to deepen our relationships with our customers by offering value-added services, both directly and through partners, that are not specifically insurance products, such as home maintenance, home monitoring, and home appliance warranties. |
1. | MGA |
2. | Agency |
3. | Insurance as a Service |
4. | Risk Retention |
• | our excess ceding commission recorded as revenue will be lower |
• | our sales and marketing expense will be lower |
• | our bottom-line results will be unchanged |
• | Premium for the risk retained by us is recognized on a pro-rata basis over the policy period. |
• | Ceding commission on premium ceded to third-party reinsurers is deferred as a liability and recognized on a pro-rata basis over the term of the policy, net of acquisition costs. To the extent ceding commission received exceeds direct acquisition costs, the excess is presented as revenue in the commission income, net line on our statements of operations and comprehensive loss. The consolidated company (Hippo and Spinnaker) began to earn ceding commission on premium ceded to third-party reinsurers in September 2020 and the ceding commission is recognized net of acquisition costs, on apro-rata basis over the term of the policy. |
• | New business submissions; |
• | Binding of new business submissions into policies; |
• | Bound policies going effective; |
• | Renewals of existing policies; and |
• | Average size and premium rate of bound policies. |
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
($ in millions) | ||||||||
Total Generated Premium | $ | 606.1 | $ | 333.6 | ||||
Total Revenue | 91.2 | 51.6 | ||||||
Net Loss attributable to Hippo | (371.4 | ) | (141.5 | ) | ||||
Adjusted EBITDA | (172.4 | ) | (90.4 | ) | ||||
Gross Loss Ratio | 138 | % | 109 | % | ||||
Net Loss Ratio | 217 | % | 148 | % |
2021 | 2020 | Change | ||||||||||
Gross Written Premium | $ | 477.3 | $ | 116.1 | $ | 361.2 | ||||||
Gross Placed Premium | 128.8 | 217.5 | (88.7 | ) | ||||||||
Total Generated Premium | $ | 606.1 | $ | 333.6 | $ | 272.5 | ||||||
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Net loss attributable to Hippo | $ | (371.4 | ) | $ | (141.5 | ) | ||
Adjustments: | ||||||||
Net investment income | (0.3 | ) | (1.1 | ) | ||||
Depreciation and amortization | 11.0 | 6.7 | ||||||
Interest expense | 26.1 | 3.5 | ||||||
Stock-based compensation | 24.3 | 17.2 | ||||||
Fair value adjustments | 172.6 | 22.4 | ||||||
Gain on extinguishment of debt | (47.0 | ) | — | |||||
Contingent consideration charge | 3.5 | 3.4 | ||||||
Other one-off transactions | 8.1 | 0.8 | ||||||
Income taxes (benefit) expense | 0.7 | (1.8 | ) | |||||
Adjusted EBITDA | $ | (172.4 | ) | $ | (90.4 | ) | ||
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Gross Losses and LAE | $ | 515.4 | $ | 106.9 | ||||
Gross Earned Premium | 374.5 | 98.0 | ||||||
Gross Loss Ratio | 138 | % | 109 | % |
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
PCS component of gross loss ratio | 71 | % | 48 | % | ||||
Large loss component of the gross loss ratio (1) | 13 | % | 11 | % | ||||
Non-PCS, non-large loss component of gross loss ratio | 54 | % | 50 | % | ||||
Gross loss ratio | 138 | % | 109 | % |
(1) | Defined as the excess portion of non-weather losses in excess of $0.1 million loss per claim |
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Net Losses and LAE | $ | 84.4 | $ | 25.3 | ||||
Net Earned Premium | 38.9 | 17.1 | ||||||
Net Loss Ratio | 217 | % | 148 | % |
Year Ended December 31, | ||||||||||||||||
2021 | 2020 | Change | % Change | |||||||||||||
Revenue: | ||||||||||||||||
Net earned premium | $ | 38.9 | $ | 17.1 | $ | 21.8 | 127 | % | ||||||||
Commission income, net | 37.5 | 27.1 | 10.4 | 38 | % | |||||||||||
Service and fee income | 14.5 | 6.3 | 8.2 | 130 | % | |||||||||||
Net investment income | 0.3 | 1.1 | (0.8 | ) | (73 | )% | ||||||||||
Total revenue | 91.2 | 51.6 | 39.6 | 77 | % | |||||||||||
Expenses: | ||||||||||||||||
Losses and loss adjustment expenses | 84.4 | 25.3 | 59.1 | 234 | % | |||||||||||
Insurance related expenses | 41.7 | 19.3 | 22.4 | 116 | % | |||||||||||
Technology and development | 36.2 | 18.0 | 18.2 | 101 | % | |||||||||||
Sales and marketing | 95.0 | 69.4 | 25.6 | 37 | % | |||||||||||
General and administrative | 49.2 | 36.8 | 12.4 | 34 | % | |||||||||||
Interest and other (income) expense | 198.9 | 26.0 | 172.9 | 665 | % | |||||||||||
Gain on extinguishment of debt | (47.0 | ) | — | (47.0 | ) | N/A | ||||||||||
Total expenses | 458.4 | 194.8 | 263.6 | 135 | % | |||||||||||
Loss before income taxes | (367.2 | ) | (143.2 | ) | (224.0 | ) | 156 | % | ||||||||
Income taxes (benefit) expense | 0.7 | (1.8 | ) | 2.5 | (139 | )% | ||||||||||
Net loss | (367.9 | ) | (141.4 | ) | (226.5 | ) | 160 | % | ||||||||
Net income attributable to noncontrolling interests, net of tax | 3.5 | 0.1 | 3.4 | 3400 | % | |||||||||||
Net loss attributable to Hippo | $ | (371.4 | ) | $ | (141.5 | ) | $ | (229.9 | ) | 162 | % | |||||
Other comprehensive income: | ||||||||||||||||
Change in net unrealized gain on available-for-sale | (0.8 | ) | — | (0.8 | ) | N/A | ||||||||||
Comprehensive loss attributable to Hippo | $ | (372.2 | ) | $ | (141.5 | ) | $ | (230.7 | ) | 163 | % | |||||
Year Ended December 31, | ||||||||||||
2021 | 2020 | Change | ||||||||||
Gross written premium | $ | 477.3 | $ | 116.1 | $ | 361.2 | ||||||
Ceded written premium | (434.8 | ) | (78.4 | ) | (356.4 | ) | ||||||
Net written premium | 42.5 | 37.7 | 4.8 | |||||||||
Change in unearned premium | (3.6 | ) | (20.6 | ) | 17.0 | |||||||
Net earned premium | $ | 38.9 | $ | 17.1 | $ | 21.8 | ||||||
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Amortization of deferred direct acquisition costs, net | $ | 13.9 | $ | 3.7 | ||||
Underwriting costs | 8.1 | 4.0 | ||||||
Employee-related costs (1) | 7.2 | 3.0 | ||||||
Amortization of capitalized internal use software | 4.9 | 2.6 | ||||||
Other (2) | 7.6 | 6.0 | ||||||
Total | $ | 41.7 | $ | 19.3 | ||||
(1) | included in Employee-related costs are $4.2 million and $0.8 million related to our underwriting department, respectively. |
(2) | included in Other are $5.3 million and $1.4 million related to overhead allocations, consultants, product filings, agent appointment fees, and other operating expenses, respectively. |
Year Ended December 31, | ||||||||||||
2021 | 2020 | Change | ||||||||||
Net cash provided by (used in): | ||||||||||||
Operating activities | $ | (124.5 | ) | $ | (65.4 | ) | $ | (59.1 | ) | |||
Investing activities | $ | (30.0 | ) | $ | (2.3 | ) | $ | (27.7 | ) | |||
Financing activities | $ | 480.8 | $ | 518.1 | $ | (37.3 | ) |
December 31, 2021 | December 31, 2020 | |||||||||||||||
Gross | Net | Gross | Net | |||||||||||||
Loss and loss adjustment reserves | ||||||||||||||||
IBNR | $ | 195.0 | $ | 23.4 | $ | 72.1 | $ | 8.1 | ||||||||
Case reserves | 65.8 | 20.6 | 32.9 | 4.9 | ||||||||||||
Total reserves | $ | 260.8 | $ | 44.0 | $ | 105.1 | $ | 13.0 | ||||||||
10% increase in ultimate loss and loss adjustment expenses | 10% decrease in ultimate loss and loss adjustment expenses | |||||||
Impact on: | ||||||||
Loss and loss adjustment expense reserves, net | $ | 10.4 | $ | (11.5 | ) |
• | paid and unpaid amounts recoverable; |
• | any balances in dispute or subject to legal collection; |
• | the financial wellbeing of a reinsurer (i.e. insolvent, liquidated, in receivership or otherwise subject to formal or informal regulatory restriction); |
• | the likelihood of collection of the reinsurance recovery considering factors such as, amounts outstanding, length of collection periods, disputes, any collateral or letters of credit held and other relevant factors. |
• | relevant precedent transactions involving our capital stock; |
• | the liquidation preferences, rights, preferences, and privileges of our redeemable convertible preferred stock relative to the common stock; |
• | our actual operating and financial performance; |
• | current business conditions and projections; |
• | our stage of development; |
• | the likelihood and timing of achieving a liquidity event for the shares of common stock underlying the stock options, such as an initial public offering, given prevailing market conditions; |
• | any adjustment necessary to recognize a lack of marketability of the common stock underlying the granted options; |
• | recent secondary stock sales and tender offers; |
• | the market performance of comparable publicly traded companies; and |
• | U.S. and global capital market conditions. |
Name | Age | Position(s) | ||
Executive Officers | ||||
Assaf Wand | 47 | Chief Executive Officer, Co-Founder and Director | ||
Richard McCathron | 50 | President and Director | ||
Stewart Ellis | 46 | Chief Financial Officer | ||
Ran Harpaz | 48 | Chief Technology Officer | ||
Simon Fleming-Wood | 53 | Chief Marketing Officer | ||
Non-Employee Directors | ||||
Amy Errett (3) | 64 | Director | ||
Eric Feder (2) | 52 | Director | ||
Lori Dickerson Fouché (3) | 52 | Director | ||
Hugh R. Frater (1) | 66 | Director | ||
Noah Knauf (1)(2) | 42 | Director | ||
Sam Landman (2)(3) | 42 | Director | ||
Sandra Wijnberg (1)(3) | 65 | Director |
(1) | Member of the audit, risk and compliance committee (the “Audit Committee”). |
(2) | Member of the compensation committee (the “Compensation Committee”). |
(3) | Member of the nominating and corporate governance committee (the “Nominating and Corporate Governance Committee”). |
• | the Class I directors are Eric Feder, Noah Knauf and Sam Landman, and their terms will expire at our 2022 annual meeting of stockholders; |
• | the Class II directors are Richard McCathron, Lori Dickerson Fouché and Hugh R. Frater, and their terms will expire at our 2023 annual meeting of stockholders; and |
• | the Class III directors are Assaf Wand, Sandra Wijnberg and Amy Errett, and their terms will expire at the 2024 annual meeting of stockholders. |
• | appointing, approving the compensation of, and assessing the independence of our independent registered public accounting firm; |
• | discussing with Hippo’s independent registered public accounting firm their independence from management; |
• | reviewing with Hippo’s independent registered public accounting firm the scope and results of their audit; |
• | pre-approving all audit and permissiblenon-audit services to be performed by Hippo’s independent registered public accounting firm; |
• | setting clear hiring policies for employees or former employees of Hippo’s independent registered public accounting firm; |
• | overseeing the financial reporting process and discussing with management Hippo’s independent registered public accounting firm the interim and annual financial statements that Hippo files with the SEC; |
• | overseeing Hippo’s risk assessment and risk management, including with respect to the underwriting and pricing of insurable risks, the settlement of claims, the appropriate levels of retained risk and other insurance-related matters; |
• | establishing procedures for the receipt, retention, and treatment of complaints received by Hippo regarding accounting, internal accounting controls, or auditing matters; |
• | reporting regularly to the Hippo board of directors regarding the activities of the Audit Committee; |
• | reviewing and monitoring Hippo’s earnings releases, accounting principles, accounting policies, financial and accounting controls, and compliance with legal and regulatory requirements; and |
• | periodically reviewing and reassessing the audit committee charter. |
• | reviewing and approving corporate goals and objectives relevant to the compensation of Hippo’s Chief Executive Officer, evaluating the performance of Hippo’s Chief Executive Officer in light of these goals and objectives and setting or making recommendations to Hippo’s board of directors regarding the compensation of Hippo’s Chief Executive Officer; |
• | reviewing and setting or making recommendations to Hippo’s board of directors regarding the compensation of Hippo’s other executive officers; |
• | making recommendations to Hippo’s board of directors regarding the compensation of Hippo’s directors; |
• | reviewing and approving or making recommendations to Hippo’s board of directors regarding Hippo’s incentive compensation and equity-based plans and arrangements; and |
• | appointing and overseeing any compensation consultants. |
• | identifying individuals qualified to become members of Hippo’s Board of Directors, consistent with criteria approved by Hippo’s Board of Directors; |
• | recommending to Hippo’s Board of Directors the nominees for election to Hippo’s Board of Directors at annual meetings of Hippo’s stockholders; |
• | overseeing the annual self-evaluation of Hippo’s Board of Directors and management; |
• | reviewing Board committee structure and recommending directors to serve as committee members; and |
• | developing and recommending to Hippo’s Board of Directors a set of corporate governance guidelines. |
• | Assaf Wand, Co-Founder and Chief Executive Officer; |
• | Richard McCathron, President; and |
• | Stewart Ellis, Chief Financial Officer. |
Name and Principal Position | Year | Salary ($) (1) | Option Awards ($) (2) | Stock Awards ($) (2) | All Other Compensation ($) (3) | Total ($) | ||||||||||||||||||
Assaf Wand, Co-Founder and Chief Executive Officer | 2021 | 368,216 | — | — | 1,204,053 | 1,572,269 | ||||||||||||||||||
2020 | 258,333 | — | — | — | 258,333 | |||||||||||||||||||
Richard McCathron, President | 2021 | 383,333 | 1,106,327 | 1,388,781 | — | 2,878,441 | ||||||||||||||||||
2020 | 300,000 | 1,369,064 | — | 31,222 | 1,700,286 | |||||||||||||||||||
Stewart Ellis, Chief Financial Officer | 2021 | 391,667 | 1,105,481 | 1,388,781 | 1,170,703 | 4,056,632 | ||||||||||||||||||
2020 | 350,000 | 1,158,035 | — | — | 1,508,035 |
(1) | From September to December 2021, compensation amounts received in non-U.S. currency have been converted into U.S. dollars using an exchange rate of 3.19 New Israeli Shekel (“NIS”) per dollar (which was the average exchange rate for 2021). |
(2) | Amounts reported represent the aggregate grant-date fair value of the stock options awarded to the NEOs, calculated in accordance with ASC Topic 718. Assumptions used in the calculation of these amounts are included in Note 17 to our financial statements included elsewhere in this prospectus. The NEOs will only realize compensation to the extent the trading price of our common stock is greater than the exercise price of such stock options. |
(3) | Amounts reported in 2021 represent the aggregate dollar value of the forgiveness of Messrs. Wand’s and Ellis’ loan extended pursuant to that certain Partial Recourse Promissory Note and Stock Pledge Agreement by and between us and Mr. Wand and the applicable NEO all interest accrued thereon has been forgiven upon the consummation of the Business Combination. Amounts reported in 2020 represent travel and lodging expenses in connection with Mr. McCathron’s travel from his home office in Austin, Texas to Hippo’s offices in the Bay Area, California. |
Option Awards | Stock Awards | |||||||||||||||||||||||||
Name | Vesting Commencement Date | Number of Securities Underlying Unexercised Options (#) Exercisable | Number of Securities Underlying Unexercised Options (#) Unexercisable | Option Exercise Price ($) | Option Expiration Date | Number of Shares or Units of Stock That Have Not Vested | Market Value of Shares or Units That Have Not Vested ($) (1) | |||||||||||||||||||
Assaf Wand | 10/15/2019 (2) | 4,586,013 | 4,586,020 | 0.81 | 10/14/2029 | — | — | |||||||||||||||||||
1/23/2019 (3) | — | — | — | — | 928,719 | 2,628,275 | ||||||||||||||||||||
Richard McCathron | 11/15/2021 (4) | — | — | — | — | 345,468 | 977,674 | |||||||||||||||||||
9/15/2021 (5) | 39,617 | 594,258 | 5.87 | 9/10/2031 | — | — | ||||||||||||||||||||
12/1/2020 (6) | — | — | — | — | 782,353 | 2,214,059 | ||||||||||||||||||||
8/27/2020 (7) | 231,811 | 463,622 | 1.06 | 9/28/2030 | — | — | ||||||||||||||||||||
5/13/2019 (7) | 74,792 | 307,874 | 0.34 | 5/15/2029 | — | — | ||||||||||||||||||||
1/23/2018 (8) | 130,992 | 32,601 | 0.16 | 1/23/2028 | — | — | ||||||||||||||||||||
Stewart Ellis | 11/9/2021 (4) | — | — | — | — | 345,468 | 977,674 | |||||||||||||||||||
9/15/2021 (5) | 39,617 | 594,258 | 5.87 | 9/10/2031 | — | — | ||||||||||||||||||||
12/1/2020 (9) | — | — | — | — | 782,353 | 2,214,059 | ||||||||||||||||||||
2/25/2019 (10) | — | — | — | — | 1,041,918 | 2,948,628 |
(1) | Represents the fair market value per share of our common stock of $2.83 on December 31, 2021, multiplied by the number of shares that had not vested as of that date. |
(2) | 1/4th of the shares subject to the option vest on the first anniversary of the vesting commencement date, and 1/16th of the shares subject to the option vest on each quarterly anniversary thereafter, subject to continued service with us through the applicable vesting date. If the NEO’s employment with us is terminated without cause or the NEO’s employment is constructively terminated in connection with a change of control, 50% of the shares subject to the option will vest and become exercisable on the date of termination. |
(3) | Mr. Wand purchased 3,429,118 shares upon early exercise of his option prior to vesting. The unvested shares are subject to repurchase by us at the original exercise price of $0.34 per share upon a termination of Mr. Wand’s service. The shares vest as to 1/48th of the shares on each monthly anniversary of the vesting commencement date, subject to continued service with us through the applicable vesting date. Notwithstanding the foregoing, 100% of the unvested shares will vest upon a change in control. |
(4) | The RSUs shall vest in 1/16th of the total number of RSUs for each of the first four quarters following the Vesting Commencement Date, and thereafter shall vest in respect of 3/16ths of the remaining four quarters, subject to continued service with us through the applicable vesting date. |
(5) | 1/16th of the shares on each of the first four quarterly anniversary following the vesting commencement date, and 3/16ths of the shares on each of the remaining four quarterly anniversaries thereafter, subject to continued service with us through the applicable vesting date. |
(6) | Mr. McCathron purchased 1,043,149 shares upon early exercise of an option prior to vesting. The unvested shares are subject to repurchase by us at the original exercise price of $1.06 per share upon a termination of Mr. McCathron’s service. The shares vest as to 1/48th of the shares vest on each monthly anniversary of the vesting commencement date, subject to continued service with us through the applicable vesting date. |
(7) | 1/48th of the shares subject to the option vest on each monthly anniversary of the vesting commencement date, subject to continued service with us through the applicable vesting date. |
(8) | 1/16th of the shares subject to the option vest on each quarterly anniversary of the vesting commencement date, subject to continued service with us through the applicable vesting date. |
(9) | Mr. Ellis purchased 1,043,149 shares upon early exercise of his option prior to vesting. The unvested shares are subject to repurchase by us at the original exercise price of $1.06 per share upon a termination of Mr. Ellis’s service. The shares vest as to 1/48th of the shares on each monthly anniversary of the vesting commencement date, subject to continued service with us through the applicable vesting date. Notwithstanding the foregoing, 100% of the unvested shares will vest upon a change in control. |
(10) | Mr. Ellis purchased 3,334,136 shares upon early exercise of his option prior to vesting. The unvested shares are subject to repurchase by us at the original exercise price of $0.34 per share upon a termination of Mr. Ellis’s service. 1/4th of the shares will vest on the on first anniversary of the vesting commencement date, and the remaining 3/4th vest quarterly over three years subject to continued service with us through the applicable vesting date. Notwithstanding the foregoing, 100% of the unvested shares will vest upon a change in control. |
• | Each non-employee director will receive an annual cash retainer in the amount of $35,000 per year. The lead independent director of the board will receive an additional annual cash compensation in the amount of $22,500 per year for such lead independent director’s service on the board. |
• | The chairperson of the audit committee will receive additional annual cash compensation in the amount of $20,000 per year for such chairperson’s service on the audit committee. Each non-chairperson member of the audit committee will receive additional annual cash compensation in the amount of $10,000 per year for such member’s service on the audit committee. |
• | The chairperson of the compensation committee will receive additional annual cash compensation in the amount of $12,000 per year for such chairperson’s service on the compensation committee. Each non-chairperson member of the compensation committee will receive additional annual cash compensation in the amount of $6,000 per year for such member’s service on the compensation committee. |
• | The chairperson of the nominating and corporate governance committee will receive additional annual cash compensation in the amount of $8,000 per year for such chairperson’s service on the nominating and corporate governance committee. Each non-chairperson member of the nominating and corporate governance committee will receive additional annual cash compensation in the amount of $4,000 per year for such member’s service on the nominating and corporate governance committee. |
Name | Fees Earned or Paid in Cash ($) | Stock Awards ($) (1) | Total ($) | |||||||||
Amy Errett | 16,250 | 132,600 | 148,850 | |||||||||
Eric Feder | 17,083 | 132,600 | 149,683 | |||||||||
Lori Dickerson Fouché | 19,583 | 132,600 | 152,183 | |||||||||
Hugh R. Frater | 18,750 | 132,600 | 151,350 | |||||||||
Noah Knauf | 23,750 | 132,600 | 156,350 | |||||||||
Sam Landman | 18,750 | 132,600 | 151,350 | |||||||||
Sandra Wijnberg | 33,958 | 132,600 | 166,558 |
(1) | Amounts reported represent the aggregate grant-date fair value of the restricted stock units awarded to the non-employee directors, calculated in accordance with ASC Topic 718. Assumptions used in the calculation of these amounts are included in Note 17 to our financial statements included elsewhere in this prospectus. |
Name | Stock Awards Outstanding at Year End (#) | Option Awards Outstanding at Year End (#) | ||||||
Amy Errett | 30,000 | |||||||
Eric Feder | 30,000 | |||||||
Lori Dickerson Fouché | 30,000 | |||||||
Hugh R. Frater | 30,000 | |||||||
Noah Knauf | 30,000 | |||||||
Sam Landman | 30,000 | |||||||
Sandra Wijnberg | 30,000 | 243,401 |
• | each person who is known to be the beneficial owner of more than 5% of shares of Hippo Holdings common stock; |
• | each of Hippo Holdings’ current named executive officers and directors; and |
• | all current executive officers and directors of Hippo Holdings as a group. |
Number of Shares of Hippo Holdings Common Stock | +60 Days Vested | Number of Shares Beneficially Owned | % | |||||||||||||
Name and Address of Beneficial Owner (1) | ||||||||||||||||
Five Percent Holders : | ||||||||||||||||
Fifth Wall Ventures, L.P. and affiliates (2) | 51,812,546 | — | 51,812,546 | 9.14 | % | |||||||||||
LEN FW INVESTOR, LLC and affiliates (3) | 77,189,421 | — | 77,189,421 | 13.61 | % | |||||||||||
Mitsui Sumitomo Insurance Co., Ltd (4) | 39,555,425 | — | 39,555,425 | 6.97 | % | |||||||||||
Bond Capital Fund, LP and affiliate (5) | 30,003,193 | — | 30,003,193 | 5.29 | % | |||||||||||
Named Executive Officers and Directors | ||||||||||||||||
Assaf Wand (6) | 32,384,660 | 4,586,013 | 36,970,673 | 6.52 | % | |||||||||||
Richard McCathron (7) | 2,771,530 | 651,072 | 3,422,602 | * | ||||||||||||
Stewart Ellis (8) | 3,391,203 | 39,617 | 3,430,820 | * | ||||||||||||
Amy Errett | — | — | — | — | ||||||||||||
Eric Feder (9) | 125,000 | — | 125,000 | * | ||||||||||||
Lori Dickerson Fouché | — | — | — | — | ||||||||||||
Hugh R. Frater (10) | 1,076,362 | — | 1,076,362 | * | ||||||||||||
Noah Knauf (11) | 167,213 | — | 167,213 | * | ||||||||||||
Sam Landman | 11,813 | — | 11,813 | * | ||||||||||||
Sandra Wijnberg (12) | 117,000 | 101,416 | 218,416 | * | ||||||||||||
Ran Harpaz (13) | 2,104,125 | 66,582 | 2,170,707 | * | ||||||||||||
Simon Fleming-Wood | — | 544,684 | 544,684 | * | ||||||||||||
All executive officers and directors as a group | 42,148,906 | 5,989,384 | 48,138,290 | 8.49 | % |
* | Less than one percent |
(1) | Unless otherwise noted, the business address of each of those listed in the table above is c/o Hippo Holdings Inc., 150 Forest Avenue, Palo Alto, California 94301. |
(2) | Based solely on a Schedule 13G filed with the SEC on August 12, 2021 and a Form 4 filed with the SEC on April 12, 2022. Consists of 51,812,546 shares of common stock, of which (i) 25,974,574 are shares of common stock directly held by Fifth Wall Ventures SPV IV, L.P., (ii) 229,302 are common stock directly held by Fifth Wall Ventures SPV XVII, L.P. and (iii) 25,608,670 are shares of common stock directly held by Fifth Wall Ventures, L.P. Fifth Wall Ventures GP, LLC is the general partner of Fifth Wall Ventures SPV XVII, L.P., Fifth Wall Ventures SPV IV, L.P. and Fifth Wall Ventures, L.P., each a Delaware limited partnership (the “Subsidiary Funds”). Fifth Wall Ventures Management, L.P. serves as the sole manager of |
Fifth Wall Ventures GP, LLC. Fifth Wall Ventures Management GP, LLC is the general partner of Fifth Wall Ventures Management, L.P. Each of Fifth Wall Ventures GP, LLC, Fifth Wall Ventures Management, L.P. and Fifth Wall Ventures Management GP, LLC expressly disclaims beneficial ownership of the shares held by each Subsidiary Fund. Each Subsidiary Fund expressly disclaims ownership of any shares held by any other Subsidiary Fund. Fifth Wall Ventures SPV IV, L.P. has granted LEN FW Investor, LLC an irrevocable voting proxy in respect of the shares referred to in clause (i) herein, which are held directly by Fifth Wall Ventures SPV IV L.P. The address of the above persons and entities is 6060 Center Drive, Los Angeles, California 90045. |
(3) | Based solely on a Schedule 13D/A filed with the SEC on April 12, 2022. Consists of 77,189,421 shares of Hippo Holdings common stock, as to which (i) 51,465,797 are common stock held directly by LEN FW Investor, LLC and (ii) 25,723,623 are common stock held directly by Fifth Wall Ventures SPV IV L.P. Fifth Wall Ventures SPV IV, L.P. has granted LEN FW Investor, LLC an irrevocable voting proxy in respect of the shares referred to in clause (ii) herein, which are held directly by Fifth Wall Ventures SPV IV L.P. Because LEN FW Investor, LLC has agreed not to vote with regard to more than 9.99% of the voting securities of Hippo Holdings, and LEN FW Investor, LLC directly owns or has voting power with regard to more than 9.99% of Hippo Holdings common stock, LEN FW Investor, LLC denies beneficial ownership of the shares as to which it holds an irrevocable proxy to the extent they would increase LEN FW Investor, LLC’s voting power above 9.99%. Eric Feder is currently a member of our board of directors and an officer of the parent of LEN FW Investor, LLC. The address of the above persons and entities is 700 Northwest 107th Avenue, Miami, Florida 33172. |
(4) | Based solely on a Schedule 13D filed with the SEC on August 12, 2021. Mitsui Sumitomo Insurance Co., Ltd.’s address is 9, Kanda-Surugadai 3-chome, Chiyoda-Ku, Tokyo, Japan. |
(5) | Based solely on a Schedule 13D filed with the SEC on February 9, 2022. Consists of 29,962,810 shares of common stock beneficially owned by BOND Capital Fund, LP and 40,383 shares of Common Stock beneficially owned by BOND Capital Founders Fund, LP, all of which are held of record by BOND Capital Fund, LP as nominee for BOND Capital Fund, LP and BOND Capital Founders Fund, LP (together, the “BOND Funds”). The general partner of the Bond Funds is BOND Capital Associates, LLC. Noah Knauf, a member of our board of directors, is a managing member of BOND Capital Associates, LLC and shares voting and dispositive power over the shares held for the account of the BOND Funds. The address of each of the BOND Funds is 100 The Embarcadero, San Francisco, California 94105. |
(6) | Consists of (i) 36,970,673 shares of common stock, of which approximately 17,151,793 shares are held by Mr. Wand and 15,232,867 shares are held by Mr. Wand as trustee of a trust, and (ii) approximately 4,586,013 shares of common stock issuable pursuant to Hippo options, all of which are held directly by Mr. Wand. |
(7) | Consists of (i) 3,422,602 shares of Hippo Holdings common stock, of which approximately 2,771,530 shares are held by Mr. McCathron and (ii) 651,072 shares of common stock issuable pursuant to Hippo options. |
(8) | Consists of (i) 3,391,203 shares of common stock, of which approximately 3,132,825 shares are held by Mr. Ellis and 258,375 shares are held by Mr. Ellis as trustee of a trust, and (ii) approximately 39,617 shares of common stock issuable pursuant to Hippo options, all of which are held directly by Mr. Ellis. |
(9) | 125,000 shares of common stock are held under Beep Investment LLC, all of which is own by Eric Feder. |
(10) | Consists of 1,076,362 shares of common stock, all of which are held by Mr. Frater as trustee of a trust. |
(11) | Noah Knauf, a member of our board of directors, is a managing member of BOND Capital Associates, LLC and shares voting and dispositive power over the shares held for the account of the BOND Funds. |
(12) | Consists of (i) 218,416 shares of common stock, of which approximately 177,000 shares are held by Mrs. Wijnberg as trustee of a trust and (ii) 101,416 shares of common stock issuable pursuant to Hippo options |
(13) | Consists of (i) 2,170,707 shares of common stock, of which approximately 2,104,125 shares are held by Mr. Harpaz and (ii) 66,582 shares of common stock issuable pursuant to Hippo options. |
• | up to 55,000,000 PIPE Shares; |
• | up to 14,592,527 shares of common stock held by Hippo Holdings holders issuable upon the exercise of equity awards; |
• | up to 4,400,000 shares of common stock issuable upon the exercise of private placement warrants; |
• | up to 316,640,538 shares of Hippo Holdings common stock; and |
• | up to 637,463 shares of common stock issuable upon the exercise of Hippo Holdings warrants; and |
• | up to 4,400,000 private placement warrants. |
Shares of Common Stock | ||||||||||||||||
Name | Number Beneficially Owned Prior to Offering(1) | Number Registered for Sale Hereby | Number Beneficially Owned After Offering | Percent Owned After Offering(2) | ||||||||||||
140 Summer Partners Master Fund LP (3) | 500,000 | 500,000 | — | — | ||||||||||||
Ally Financial Inc. (4) | 200,000 | 200,000 | — | — | ||||||||||||
Alyeska Master Fund, L.P. (5) | 1,271,007 | 1,260,000 | — | — | ||||||||||||
Assaf Wand (6) | 36,906,828 | 36,906,828 | 27,680,121 | 4.9 | % | |||||||||||
Beagle Limited (7) | 25,000 | 25,000 | — | — | ||||||||||||
BHHP LLC (8) | 500,000 | 500,000 | — | — | ||||||||||||
Bond Capital Fund, LP (9) | 30,003,193 | 30,003,193 | 15,001,597 | 2.6 | % | |||||||||||
Byron Auguste (10) | 30,000 | 30,000 | — | — | ||||||||||||
David Mayer de Rothschild (11) | 140,000 | 140,000 | — | — |
Shares of Common Stock | ||||||||||||||||
Name | Number Beneficially Owned Prior to Offering(1) | Number Registered for Sale Hereby | Number Beneficially Owned After Offering | Percent Owned After Offering(2) | ||||||||||||
Diameter Master Fund LP (12) | 881,128 | 881,128 | — | — | ||||||||||||
EMJ Master Fund LP (13) | 777,750 | 777,750 | — | — | ||||||||||||
Entities Affiliated with Brosh Capital (14) | 500,000 | 500,000 | — | — | ||||||||||||
Entities Affiliated with Clal Insurance (15) | 13,880,906 | 1,000,000 | 12,880,906 | 2.3 | % | |||||||||||
Entities Affiliated with Comcast (16) | 26,823,284 | 26,823,284 | 13,411,642 | 2.4 | % | |||||||||||
Entities Affiliated with Corbin Capital (17) | 600,000 | 600,000 | — | — | ||||||||||||
Entities Affiliated with Darlington Partners (18) | 3,000,000 | 3,000,000 | — | — | ||||||||||||
Entities Affiliated with Fifth Wall Ventures (19) | 51,812,546 | 51,812,546 | 25,906,273 | 4.6 | % | |||||||||||
Entities Affiliated with Horizon (20) | 26,872,544 | 26,872,544 | 12,436,272 | 2.2 | % | |||||||||||
Entities Affiliated with Luxor Capital (21) | 592,923 | 524,695 | — | — | ||||||||||||
Entities Affiliated with Park West (22) | 4,000,000 | 4,000,000 | — | — | ||||||||||||
Entities Affiliated with Saba Capital (23) | 2,000,000 | 2,000,000 | — | — | ||||||||||||
Entities Affiliated with Sentinel Dome (24) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Entities Managed by UBS (25) | 300,000 | 300,000 | — | — | ||||||||||||
Gan Eden Ventures, Inc. (26) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Garden Fund, LLC (27) | 100,000 | 100,000 | — | — | ||||||||||||
Gores HP, LLC (28) | 9,926 | 9,926 | — | — | ||||||||||||
The HGC Fund LP (29) | 500,000 | 500,000 | — | — | ||||||||||||
Hound Partners, LLC (30) | 529,682 | 529,682 | — | — | ||||||||||||
Hugh R. Frater Irrevocable Trust Dtd 12/11/2012 (31) | 1,076,362 | 1,076,362 | 807,272 | * | ||||||||||||
Invus Public Equities, L.P. (32) | 600,000 | 600,000 | — | — | ||||||||||||
Julie Hanna (33) | 30,000 | 30,000 | — | — | ||||||||||||
Lee Linden (34) | 30,000 | 30,000 | — | — | ||||||||||||
Len FW Investor, LLC (35) | 77,189,421 | 77,189,421 | 38,544,711 | 6.8 | % | |||||||||||
Linda Rottenberg (36) | 30,000 | 30,000 | — | — | ||||||||||||
Madison Rock Investments LP (37) | 100,000 | 100,000 | — | — | ||||||||||||
Octahedron Master Fund, L.P. (38) | 250,000 | 250,000 | — | — | ||||||||||||
Psagot Provident Funds and Pensions Ltd. (39) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Reinvent Capital Fund LP (40) | 1,000,000 | 1,000,000 | ||||||||||||||
Reinvent Sponsor Z LLC (41) | 10,030,000 | 10,030,000 | 4,222,500 | * | ||||||||||||
Ribbit Capital VI, L.P. (42) | 300,000 | 300,000 | — | — | ||||||||||||
Richard McCathron (43) | 3,422,602 | 3,176,134 | 2,566,952 | * | ||||||||||||
RPM Ventures III, L.P. (44) | 30,644,982 | 30,644,982 | 15,322,491 | 2.7 | % | |||||||||||
Sandra Wijnberg (45) | 218,416 | 81,130 | 60,848 | * | ||||||||||||
Senator Global Opportunity Master Fund L.P. (46) | 2,250,000 | 2,250,000 | — | — | ||||||||||||
Shapero 2015 Trust (47) | 75,000 | 75,000 | — | — | ||||||||||||
Slate Path Master Fund LP (48) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Smith’s Point Family Partners LLC (49) | 700,000 | 700,000 | — | — | ||||||||||||
Standard Latitude Master Fund Ltd. (50) | 4,000,000 | 4,000,000 | — | — | ||||||||||||
Stewart Ellis (51) | 3,172,442 | 3,172,442 | 2,379,332 | * | ||||||||||||
Transcend Partners LLC (52) | 200,000 | 200,000 | — | — | ||||||||||||
West Coast Equity Partners LLC (53) | 600,000 | 600,000 | — | — | ||||||||||||
XN Exponent Master Fund LP (54) | 4,500,000 | 4,500,000 | — | — |
* | Less than 1% |
(1) | This table includes shares beneficially owned as determined in accordance with Rule 13d-3 of the Exchange Act. Included in these amounts are the PIPE Shares, Sponsor Shares, Hippo Holdings holder shares, shares of common stock issuable upon exercise of certain equity awards, shares of common stock issuable upon exercise of the Hippo Holdings Warrants and shares of common stock issuable upon exercise of the private placement warrants (collectively, the “Resale Securities”). We do not know when or in what amounts the selling securityholders will offer the Resale Securities for sale, if at all. |
(2) | The percentage of shares to be beneficially owned after completion of the offering is calculated on the basis of 567,175,909 shares of common stock outstanding, assuming the exercise of all currently outstanding warrants and the sale of all Resale Securities by the selling securityholders. |
(3) | Shares offered hereby consist of 500,000 PIPE Shares. The securities to which this filing relates are held directly by 140 Summer Partners Master Fund LP, a Delaware limited partnership (the “Fund”). 140 Summer Partners Fund GP LLC, a Delaware limited liability company, serves as the general partner of 140 Summer Partners Master Fund LP and as such has discretion over the portfolio securities beneficially owned by 140 Summer Partners Master Fund LP. Peter Rosenblum is the managing member of 140 Summer Partners Fund GP LLC and directs 140 Summer Partners Fund GP LLC operations. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. |
(4) | Shares hereby offered consist of 200,000 PIPE Shares held by Ally Ventures, a business unit of Ally Financial Inc. The business address of Ally Ventures is 300 Park Avenue, 4th Floor, New York, NY 10022. |
(5) | Shares hereby offered consist of the 1,000,000 PIPE Shares and 260,000 shares of Hippo Holdings common stock issuable upon the exercise of Hippo Holdings warrants held by Alyeska Master Fund, L.P. Alyeska Investment Group, L.P., the investment manager of Alyeska Master Fund, L.P., has voting and investment control of the shares held by Alyeska Master Fund, L.P. Anand Parekh is the Chief Executive Officer of Alyeska Investment Group, L.P. and may be deemed to be the beneficial owner of such shares. Mr. Parekh, however, disclaims any beneficial ownership of the shares held by Alyeska Master Fund, L.P. The registered address of Alyeska Master Fund, L.P. is at c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, South Church Street George Town, Grand Cayman, KY1-1104, Cayman Islands. Alyeska Investment Group, L.P. is located at 77 W. Wacker, Suite 700, Chicago IL 60601. |
(6) | Consists of (i) 36,906,828 shares of Hippo Holdings common stock, of which approximately 17,087,948 shares are held by Mr. Wand and 15,232,867 shares are held by Mr. Wand as trustee of a trust, and (ii) approximately 4,586,013 shares of Hippo Holdings common stock issuable pursuant to Hippo options of which all are held by Mr. Wand and none are held by Mr. Wand as trustee of a trust. |
(7) | Shares hereby offered consist of 25,000 PIPE Shares held directly by Beagle Limited. Beagle Limited is a corporation organized under the laws of the British Virgin Islands. Giovanni Pigozzi is the beneficial owner of Beagle Limited and has voting and/or investment control over the shares held by Beagle Limited. Mr. Pigozzi disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of Beagle Limited is 50 Rockefeller Plaza, 4th Floor, New York, New York, 10020. |
(8) | Shares hereby offered consist of 500,000 PIPE Shares held directly by BHHP LLC. BHHP LLC is a limited partnership organized under Delaware law. Chaim Tvzi Nash and Shmuel Gniwisch are the managers of Kli Capital LLP, a Delaware limited liability company and general partner of BHHP LLC, and have voting and/or investment control over the shares held by BHHP LLC. Mr. Nash and Mr. Gniwisch disclaim beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of BHHP LLC is 1083 Main Street, Champlain, New York 12919. |
(9) | Consists of 30,003,193 shares of Hippo Holdings common stock held in the name of BOND Capital Fund, LP, as nominee, for the account of BOND Capital Fund, LP and BOND Capital Founders Fund, LP (together, the “BOND Funds”). Daegwon Chae, Juliet de Baubigny, Noah Knauf, Mary Meeker, Mood Rowghani, Jay Simons and Paul Vronsky are managing members of BOND Capital Associates, LLC, the |
general partner of the BOND Funds, and share voting and dispositive power over the shares held for the account of the BOND Funds. The address of each of these entities is 100 The Embarcadero, San Francisco, California 94105. |
(10) | Consists of 30,000 shares of Hippo Holdings common stock held directly by Byron Auguste. |
(11) | Shares hereby offered consist of 140,000 PIPE Shares. |
(12) | Shares hereby offered consist of 700,000 PIPE Shares held directly by Diameter Master Fund LP and 181,128 shares of Hippo Holdings common stock issuable upon the exercise of Hippo Holdings warrants, of which (i) 140,064 are held by Diameter Master Fund LP, (ii) 16,700 are held by Diameter SPO Master Fund LP and (iii) 24,364 are held by Diameter Dislocation Master Fund LP. Diameter Capital Partners LP is the investment manager of the Diameter Master Fund LP and, therefore, has investment and voting power over these shares. Scott Goodwin and Jonathan Lewinsohn, as the sole managing members of the general partner of the investment manager, make voting and investment decisions on behalf of the investment manager. As a result, the investment manager, Mr. Goodwin and Mr. Lewinsohn may be deemed to be the beneficial owners of these shares. Notwithstanding the foregoing, each of Mr. Goodwin and Mr. Lewinsohn disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of Diameter Master Fund LP is 55 Hudson Yards, 29B, New York, New York 10001. |
(13) | Shares hereby offered consist of 700,000 PIPE Shares and 77,750 shares of Hippo Holdings common stock issuable upon the exercise of Hippo Holdings warrants held directly by EMJ Master Fund LP. EMJ Master Fund LP is a limited partnership organized pursuant to the Exempted Limited Partnership Law, 2018 of the Cayman Islands. Eric M. Jackson is the president and founder of EMJ Capital Ltd, an Ontario corporation which acts as Investment Manager to EMJ Master Fund LP and has voting and/or investment control over the shares held by EMJ Master Fund LP. Mr. Jackson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The legal address of EMJ Master Fund LP is c/o Waystone Governance Ltd., Suite 5B201, 2nd Floor, One Nexus Way, PO Box 2587, KY1-1103, Cayman Islands and the business address 1370 Don Mills Road, Suite 300, Toronto, Ontario, Canada M3B 3N7. |
(14) | Shares hereby offered consist of 500,000 PIPE Shares, of which (i) 455,000 are held by Brosh Capital Partners L.P., (ii) 22,500 are held by Halman Aldubi on behalf of Roni Biram and (iii) 22,500 are held by Halman Aldubi on behalf of Ester Deutsch. Brosh Capital Partners L.P. is a limited partnership organized under the laws of the Cayman Islands. Amir Efrati is the CEO and Director of Exodus Management Israel Ltd., which is the general partner of Brosh Capital Partners L.P. and has voting and/or investment control over the shares held by Brosh Capital Partners L.P. Mr. Efrati disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for the above-referenced entities is 4 Ariel Sharon Street, Givataim 5320047 Israel. |
(15) | Shares hereby offered consist of 1,000,000 PIPE Shares, of which (i) 430,000 are held by Clal Insurance Company Ltd. and (ii) 570,000 are held by Clal Pension and Provident Funds Ltd. (together, the “Clal Insurance Companies”). The Clal Insurance Companies are insurance companies organized under the laws of Israel. Barak Benksi and Dov Caspi are the chief investment officer and deputy chief investment officer of the Clal Insurance Companies, respectively, and have voting and/or investment control over the shares held by the Clal Insurance Companies. Mr. Benski and Mr. Caspi disclaim beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for the above-referenced entities is 4 Ariel Sharon Street, Givataim 5320047 Israel. |
(16) | Consists of 26,823,284 shares of Hippo Holdings common stock, of which (i) 26,388,639 are held by Comcast Ventures, LP and (ii) 434,645 are held by Comcast Warranty and Home Insurance. The business address for Comcast Ventures, LP and Comcast Warranty and Home Insurance is 1701 John F. Kennedy Boulevard, Philadelphia, Pennsylvania 19103. |
(17) | Shares hereby offered consist of 600,000 PIPE Shares, of which (i) 246,000 are held by Pinehurst Partners, L.P., (ii) 108,000 are held by Corbin Opportunity Fund, L.P. and (iii) 246,000 are held by Corbin ERISA Opportunity Fund, Ltd. Corbin Capital Partners, L.P. (“CCP”) is the investment manager of Pinehurst Partners, L.P., Corbin Opportunity Fund, L.P. and Corbin ERISA Opportunity Fund, Ltd. Corbin Capital Partners, L.P. and its general partner, Corbin Capital Partners Group, LLC, may be deemed beneficial owners of the Company securities being registered in the Registration Statement on behalf of Corbin ERISA Opportunity Fund, Ltd., Pinehurst Partners, L.P. and Corbin Opportunity Fund, L.P. Craig Bergstrom is the Chief Investment Officer of Corbin Capital Partners, L.P., the investment manager of Pinehurst Partners, L.P., Corbin Opportunity Fund, L.P. and Corbin ERISA Opportunity Fund, Ltd., and accordingly may be deemed to have voting and dispositive power with respect to shares held by Pinehurst Partners, L.P., Corbin Opportunity Fund, L.P. and Corbin ERISA Opportunity Fund, Ltd. Mr. Bergstrom disclaims beneficial ownership of such shares. The business address of each of the above-mentioned funds is 590 Madison Avenue, 31st Floor, New York, New York 10022. |
(18) | Shares hereby offered consist of 3,000,000 PIPE Shares, of which (i) 2,655,000 are held by Darlington Partners, LP and (ii) 345,000 are held by Darlington Partners II, LP (together, the “Darlington Funds”). Darlington Partners GP, LLC is the general partner of the Darlington Funds and have voting and/or investment control over the shares held by the Darlington Funds. Darlington Partners GP, LLC disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of the Darlington Funds is 300 Drakes Landing Road, Suite 290, Greenbrae, California 94904. |
(19) | Consists of 51,812,546 shares of Hippo Holdings common stock, of which (i) 25,974,574 are common stock directly held by Fifth Wall Ventures SPV IV L.P., (ii) 229.302 are common stock directly held by Fifth Wall Ventures SPV XVII, L.P. and (iii) 25,608,670 are common stock directly held by Fifth Wall Ventures, L.P. Fifth Wall Ventures, L.P. has granted LEN FW Investor, LLC an irrevocable voting proxy in respect of the shares referred to in clause (i) herein, which are held directly by Fifth Wall Ventures SPV IV L.P. The address of the above persons and entities is 6060 Center Drive, Los Angeles, California 90045. |
(20) | Shares hereby offered consist of 24,872,544 shares of Hippo Holdings common stock held by Digital Fortune Limited and 2,000,000 PIPE Shares, of which (i) 24,570 are held by Celestial Ally Limited, (ii) 982,801 are held by Eliot International Limited, (iii) 982,801 are held by Famous Giant Limited and (iv) 9,828 are held by Moon Stream Investments Limited. Kang Tzu Ping is the ultimate beneficial owner of Celestial Ally Limited and as such, Ms. Kang may be deemed to beneficially own the PIPE Shares directly held by Celestial Ally Limited. Chau Hoi Shuen Solina Holly is the ultimate beneficial owner of Eliot International Limited and as such, Ms. Chau may be deemed to beneficially own the PIPE Shares directly held by Eliot International Limited. Li Ka Shing is the ultimate beneficial owner of Famous Giant Limited and as such, Mr. Li may be deemed to beneficially own the PIPE Shares directly held by Famous Giant Limited. The business address of each of the above-mentioned entities is Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands. |
(21) | Shares hereby offered consist of (i) 221,253 PIPE Shares, held by Lugard Road Capital Master Fund, LP (“Lugard”) beneficially owned by Luxor Capital Group, LP, the investment manager of Lugard; (ii) 2,506 PIPE Shares held by Luxor Capital Partners Long Offshore Master Fund, LP (“Luxor Long Offshore”) beneficially owned by Luxor Capital Group, LP, the investment manager of Luxor Long Offshore; (iii) 7,532 PIPE Shares held by Luxor Capital Partners Long, LP (“Luxor Long”) beneficially owned by Luxor Capital Group, LP, the investment manager of Luxor Long; (iv) 79,222 PIPE Shares held by Luxor Capital Partners Offshore Master Fund, LP (“Luxor Offshore”) beneficially owned by Luxor Capital Group, LP, the investment manager of Luxor Offshore; (v) 126,103 PIPE Shares held by Luxor Capital Partners, LP (“Luxor Capital”) beneficially owned by Luxor Capital Group, LP, the investment manager of Luxor Capital; and (vi) 88,079 PIPE Shares held by Luxor Wavefront, LP (“Luxor Wavefront”) beneficially owned by Luxor Capital Group, LP, the investment manager of Luxor Wavefront. Christian Leone, in his position as Portfolio Manager at Luxor Capital Group, LP, may be deemed to have voting and investment power with respect to the securities owned by Luxor Long Offshore, Luxor Long, Luxor Offshore, Luxor Capital, and Luxor Wavefront. Jonathan Green, in his position as Portfolio Manager at Luxor Capital Group, LP, may be deemed to have voting and |
investment power with respect to the securities held by Lugard. Mr. Leone and Mr. Green each disclaims beneficial ownership of any of the PIPE shares over which each exercises voting and investment power. The mailing address of each of the above-mentioned funds is 1114 Avenue of the Americas, 28th Fl, New York, NY 10036. |
(22) | Shares hereby offered consist of 4,000,000 PIPE Shares, of which (i) 3,642,400 are held by Park West Investors Master Fund, Limited and (ii) 357,600 are held by Park West Partners International, Limited (collectively, the “PW Funds”). Park West Asset Management LLC is the investment manager to the PW Funds. Peter S. Park, through one or more affiliated entities, is the controlling manager of Park West Asset Management LLC. The business address for the PW Funds is c/o Park West Asset Management LLC, 900 Larkspur Landing Circle, Suite 165, Larkspur, California 94939. |
(23) | Shares hereby offered consist of 2,000,000 PIPE Shares, of which (i) 488,200 are held by Saba Capital Master Fund, Ltd., (ii) 1,325,600 are held Saba Capital Master Fund II, Ltd. and (iii) 186,200 are held by Saba Capital Master Fund III, L.P. (the “Saba Funds”). Boaz Weinstein is the managing member of the general partner of the Saba Funds investment manager and accordingly may be deemed to have voting and dispositive power with respect to shares held by the Saba Funds. Mr. Boaz disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of the Saba Funds is c/o Saba Capital Management, LP, 405 Lexington Avenue, 58th Floor, New York, New York 10174. |
(24) | Shares hereby offered consist of 1,000,000 PIPE Shares, of which (i) 565,000 are held by SDP Flagship Master Fund, L.P., (ii) 200,000 are held by NPB Manager Fund, SPC., on behalf of and for the account of Segregated Portfolio 103, (iii) 170,000 are held by SDP Opportunities Master Fund, L.P. and (iv) 65,000 are held by NPB Manager Fund, SPC., on behalf of and for the account of Segregated Portfolio 102 (together, the “Sentinel Entities”). Qazi Munirul Alam is the chief investment officer of Sentinel Dome Partners, LLC, the investment adviser to the Sentinel Entities and has voting and/or investment control over the shares held by the Sentinel Entities. The business address of the Sentinel Entities is 3 Embarcadero Center, Suite 1680, San Francisco, California 94111. |
(25) | Shares hereby offered consist of 300,000 PIPE Shares, of which (i) 137,970 are held by Nineteen77 Global Multi-Strategy Alpha Master Limited, (ii) 137,970 are held by Nineteen77 Global Merger Arbitrage Master Limited, (ii) 23,040 are held by Nineteen77 Global Merger Arbitrage Opportunity Fund and (iv) 1,020 are held by IAM Investments ICAV - O’Connor Event Driven UCITS Fund (together, the “UBS Entities”). Kevin Russell, the chief investment officer of UBS O’Connor LLC, the investment manager of the UBS Entities, has voting and/or investment control over the shares held by the UBS Entities. Mr. Russell disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for the UBS Entities is c/o UBS O’Connor LLC, One North Wacker Drive, 31st Floor, Chicago, Illinois 60606. |
(26) | Shares offered hereby consist of 1,000,000 PIPE Shares held directly by Gan Eden Ventures, Inc. Gan Eden Ventures, Inc. is a corporation organized under Canadian law. Mark Chess and Edward Weisz are the directors of Gan Eden Ventures, Inc. and have voting and/or investment control over the shares held by Gan Eden Ventures, Inc. The business address of Gan Eden Ventures, Inc. is 1 Herons Will Way, Toronto, Ontario, Canada M2J O2G. |
(27) | Shares offered hereby consist of 100,000 PIPE Shares held directly by Garden Fund, LLC. Garden Fund, LLC is a limited liability company organized under California law. The business address of Garden Fund, LLC is 1 Sansome Street, Suite 3500, San Francisco, California 94104. |
(28) | Shares hereby offered consist of 9,926 PIPE Shares held directly by Gores HP, LLC. Gores HP, LLC is a partnership organized under the laws of Delaware. The business address of Gores HP, LLC is 6260 Lookout Road, Boulder, Colorado 80301. |
(29) | Shares hereby offered consist of 500,000 PIPE Shares held in trust by Gundy Co for The HGC Fund LP. The HGC Fund LP is a limited partnership organized under the laws of Canada. Sean Kallir is the chief executive officer and primary manager of HGC Investment Management Inc., the investment manager of |
The HGC Fund LP and has voting and/or investment control over the shares held by The HGC Fund LP. The business address of The HGC Fund LP is 366 Adelaide St W, Suite 601, Toronto, ON, M5V 1R9. |
(30) | Shares hereby offered consist of 500,000 PIPE Shares and 29,682 shares of Hippo Holdings common stock issuable upon the exercise of Hippo Holdings warrants held by clients of Hound Partners, LLC. Hound Partners, LLC is a limited liability company organized under the laws of Delaware. Jonathan Auerbach is the portfolio manager of Hound Partners, LLC and has voting and/or investment control over the shares held by such clients. The business address of Hound Partners, LLC is 101 Park Avenue, 48th Floor, New York, New York 10178. |
(31) | Consists of 1,076,362 shares of Hippo Holdings common stock, all of which are held by Mr. Frater as trustee of a trust. |
(32) | Shares hereby offered consist of 600,000 PIPE Shares held directly by Invus Public Equities, L.P. Invus Public Equities Advisors, LLC (“Invus PE Advisors”) controls Invus PE, as its general partner and accordingly, may be deemed to beneficially own the shares held by Invus PE. Artal Treasury Limited (“Artal Treasury”) controls Invus PE Advisors, as its managing member and accordingly, may be deemed to beneficially own the shares held by Invus PE. Artal International S.C.A. (“Artal International”) through its Geneva branch, is the sole stockholder of Artal Treasury and may be deemed to beneficially own the 600,000 shares that Artal Treasury may be deemed to beneficially own. Artal International Management S.A. (“Artal International Management”), as the managing partner of Artal International, controls Artal International and accordingly, may be deemed to beneficially own the shares that Artal International may be deemed to beneficially own. Artal Group S.A., as the sole stockholder of Artal International Management, controls Artal International Management and accordingly, may be deemed to beneficially own the shares that Artal International Management may be deemed to beneficially own. Westend S.A. (“Westend”), as the parent company of Artal Group S.A. (“Artal Group”), controls Artal Group and accordingly, may be deemed to beneficially own the shares that Artal Group may be deemed to beneficially own. Stichting Administratiekantoor Westend (the “Stichting”), as majority shareholder of Westend, controls Westend and accordingly, may be deemed to beneficially own the shares that Westend may be deemed to beneficially own. As of August 17,2021 Mr. Amaury Wittouck, as the sole member of the board of the Stichting, controls the Stichting and accordingly, may be deemed to beneficially own the shares that the Stichting may be deemed to beneficially own. The business address of Invus Public Equities, L.P. is 750 Lexington Avenue, 30th Floor, New York, New York 10022. |
(33) | Consists of 30,000 shares of Hippo Holdings common stock held directly by Julie Hanna. |
(34) | Consists of 30,000 shares of Hippo Holdings common stock held directly by Lee Linden. |
(35) | Shares hereby offered consist of 100,000 PIPE Shares owned directly by LEN FW Investor, LLC and 77,089,421 shares of Hippo Holdings common stock, of which (i) 25,723,624 are common stock directly held by Fifth Wall Ventures SPV IV L.P., and (ii) 51,365,797 are common stock directly held by LEN FW Investor, LLC. Fifth Wall Ventures, L.P. has granted LEN FW Investor, LLC an irrevocable voting proxy in respect of the shares referred to in clause (i) herein, which are held directly by Fifth Wall Ventures SPV IV L.P. The address of the above persons and entities is 700 Northwest 107th Avenue, Miami, Florida 33172. |
(36) | Consists of 30,000 shares of Hippo Holdings common stock held directly by Linda Rottenberg. |
(37) | Shares hereby offered consist of 100,000 PIPE Shares held directly by Madison Rock Investments LP. Madison Rock Investments LP is a partnership organized under the laws of Delaware. The business address of Madison Rock Investments LP is 630 Fifth Avenue, New York, New York 10111. |
(38) | Shares hereby offered consist of 250,000 PIPE Shares held directly by Octahedron Master Fund, L.P. Octahedron Master Fund, L.P. is a limited partnership organized under the laws of the Cayman Islands. Octahedron Fund GP LLC is the general partner of Octahedron Master Fund, L.P. Rajaraman Parameswaram is the managing member of Octahedron Fund GP LLC and has voting and/or investment control over the shares held by Octahedron Master Fund L.P. Mr. Parameswaram disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for Octahedron Mater Fund, L.P. is 4126 17th Street, Suite #2, San Francisco, California 94114. |
(39) | Shares hereby offered consist of 1,000,000 PIPE Shares held directly by Psagot Provident Funds and Pensions Ltd. Psagot Provident Funds and Pensions Ltd is a management company organized under the laws of Israel. The business address for Psagot Provident Funds and Pensions Ltd is 14 Ahad Ha’am Street, Tel Aviv, Israel 6514211. |
(40) | Shares hereby offered consist of 1,000,000 PIPE Shares held directly by Reinvent Capital Fund LP. Reinvent Capital Fund GP LLC is the general partner of Reinvent Capital Fund LP. Due to its relationship with Reinvent Capital Fund LP, Reinvent Capital Fund GP LLC may be deemed to beneficially own the PIPE Shares directly held by Reinvent Capital Fund LP. Mark Pincus and Michael Thompson are the managing members of Reinvent Capital Fund GP LLC and may therefore be deemed to beneficially own the PIPE Shares held directly by Reinvent Capital Fund LP. Mr. Pincus and Mr. Thompson each disclaim beneficial ownership of the PIPE Shares held directly by Reinvent Capital Fund LP except to the extent of their pecuniary interest therein. The business address of Reinvent Capital Fund LP is 215 Park Avenue S, 11th Floor, New York, New York 10023. |
(41) | Shares offered hereby consist of (i) 5,630,000 shares of Hippo Holdings common stock held directly by the Sponsor and (ii) 4,400,000 shares of Hippo Holdings common stock issuable upon exercise of the private placement warrants. Each of Reid Hoffman, Mark Pincus, Michael Thompson, David Cohen, and Lee Linden (who are each former directors and/or officers of RTPZ), or entities related thereto, among others, are members of the Sponsor. Messrs. Hoffman and Pincus may be deemed to beneficially own shares held by the Sponsor by virtue of their shared control over the Sponsor. Other than Messrs. Hoffman and Pincus, no member of the Sponsor exercises voting or dispositive control over any of the shares held by the Sponsor. Each of Messrs. Hoffman and Pincus disclaims beneficial ownership of the ordinary shares held by the Sponsor, except to the extent of his pecuniary interest therein. The 4,400,000 private placement warrants offered hereby are held directly by the Sponsor. 5,630,000 shares of Hippo Holdings common stock are subject to a contractual lock-up as described under “Certain Relationships and Related Party Transactions - Old Hippo - Lockup Agreements. Certain Relationships and Related Party Transactions - Old Hippo - Registration Rights Agreement |
(42) | Shares hereby offered consist of 300,000 PIPE Shares held directly by Ribbit Capital VI, L.P. Ribbit Capital VI, L.P. is an exempt limited partnership organized under the laws of the Cayman Islands. Ribbit Capital GP VI, Ltd. is the general partner of Ribbit Capital VI, L.P. Meyer Malka is the director of Ribbit Capital GP VI, Ltd. and has voting and/or investment control over the shares held by Ribbit Capital VI, L.P. The business address for Ribbit Capital VI, L.P. is 362 University Avenue, Palo Alto, California 94301. |
(43) | Consists of (i) 3,422,602 shares of Hippo Holdings common stock, of which approximately 2,771,530 shares are held by Mr. McCathron and (ii) 651,072 shares of Hippo Holdings common stock issuable pursuant to Hippo options. |
(44) | Consists of 30,644,982 shares of Hippo Holdings, of which (i) 26,369,086 are common stock directly held by RPM Ventures III, L.P. and (ii) 4,275,687 are common stock directly held by BGW Ventures II, LP, an affiliate of RPM Ventures III, L.P. The address of the above persons and entities is 320 N. Main Street, Suite 400, Ann Arbor, Michigan 48104. |
(45) | Consists of (i) 218,416 shares of common stock, of which approximately 177,000 shares are held by Mrs. Wijnberg as trustee of a trust and (ii) 101,416 shares of common stock issuable pursuant to Hippo options. |
(46) | Shares hereby offered consist of 2,250,000 PIPE Shares held directly by Senator Global Opportunity Master Fund L.P. Senator Global Opportunity Master Fund L.P. is a limited partnership organized under the laws of the Cayman Islands. Senator Investment Group LP (“Senator”) is investment manager of Senator Global Opportunity Master Fund L.P. and may be deemed to have voting and dispositive power with respect to the shares. The general partner of Senator is Senator Management LLC (the “Senator GP”). Douglas Silverman controls Senator GP, and, accordingly, may be deemed to have voting and dispositive power with respect to the shares held by this selling security holder. Mr. Silverman disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as |
amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for Senator Global Opportunity Master Fund L.P. is 510 Madison Avenue, 28th Floor, New York, New York 10022. |
(47) | Shares hereby offered consist of 75,000 PIPE Shares held directly by Shapero 2015 Trust. Daniel Shapero is the trustee for Shapero 2015 Trust and has voting and/or investment control over the shares held by Shapero 2015 Trust. The business address of Shapero 2015 Trust is 920 Hamilton Avenue, Palo Alto, California 94301. |
(48) | Shares hereby offered consist of 1,000,000 PIPE Shares held directly by Slate Path Master Fund LP. Slate Path Master Fund LP is an exempted limited partnership organized under the laws of the Cayman Islands. Slate Path Capital GP LLC is the general partner of Slate Path Master Fund LP. David Greenspan is the managing member of Slate Path Capital GP LLC and has voting and/or investment control over the shares held by Slate Path Master Fund LP. Mr. Greenspan disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for Slate Path Master Fund LP is 717 Fifth Avenue, 16th Floor, New York, New York 10022. |
(49) | Shares hereby offered consist of 700,000 PIPE Shares held directly by Smith’s Point Family Partners LLC. Smith’s Point Family Partners LLC is a limited liability company organized under the laws of Pennsylvania. The business address of Smith’s Point Family Partners LLC is PO Box 500, Gladwyne, Pennsylvania 19035. |
(50) | Shares hereby offered consist of 4,000,000 PIPE Shares held by Standard Latitude Master Fund Ltd. (formerly known as 40 North Latitude Master Fund Ltd.) (“Latitude”). David Winter and David Millstone are sole managers of Standard Investments LLC, which holds the sole voting power for Latitude. Mr. Winter and Mr. Millstone are sole directors of Latitude. The business address of Latitude is c/o Standard Investments LLC, 9 West 57th Street, 46th floor, New York, NY 10019. |
(51) | Consists of (i) 3,172,442 shares of Hippo Holdings common stock, of which approximately 3,132,825 are held by Mr. Ellis and (ii) 39,617 shares of Hippo Holdings common stock issuable pursuant to Hippo options. |
(52) | Shares hereby offered consist of 200,000 PIPE Shares held directly by Transcend Partners LLC. Transcend Partners LLC is a limited liability company organized under the laws of Delaware. Malcolm Fairbairn and Emily Fairbairn are members of Transcend Partners LLC and have voting and/or investment control over the shares held by Transcend Partners LLC. The business address of Transcend Partners LLC is 10 Orginda View, Orinda, California 94563. |
(53) | Shares hereby offered consist of 600,000 PIPE Shares held directly by West Coast Equity Partners LLC. WCEP Management LLC is the managing company of West Coast Equity Partners LLC. Alexander Lazovsky, Anton Baranchuk and Sergey Yushin are the management members of WCEP Management LLC and have voting and/or investment control over the shares held by West Coast Equity Partners LLC. Mr. Lazovsky, Mr. Baranchuck and Mr. Yushin disclaim beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of West Coast Equity Partners LLC is 703 Crestview Drive, San Carlos, California 94070. |
(54) | Shares hereby offered consist of 4,500,000 PIPE Shares held directly by XN Exponent Master Fund LP. XN Exponent Master Fund LP is a limited partnership organized under the laws of the Cayman Islands. XN Exponent Advisors LLC serves as investment manager to XN Exponent Master Fund LP (the “Fund”) and has discretionary authority to make investment decisions and determine how to vote any securities held by the Fund. XN Exponent Advisors LLC is wholly owned by XN LP, a registered investment advisor. The general partner of XN LP is XN Management GP LLC, which is indirectly controlled by Gaurav Kapadia. The principal business address of the entities referenced herein is 412 West 15th Street, 13th Floor, New York, New York. |
• | Hippo was or is to be a participant following the closing of the Business Combination or Old Hippo was a participant prior to the closing of the Business Combination; |
• | the amount involved exceeds or will exceed $120,000; and |
• | any director, executive officer or beneficial holder of more than 5% of our capital stock of (i) Hippo following the closing of the Business Combination or (ii) Old Hippo prior to the closing of the Business Combination, or any immediate family member of, or person sharing the household with, any of these individuals (other than tenants or employees), had or will have a direct or indirect material interest. |
Name | Number of Shares of Series E Preferred Stock | Aggregate Purchase Price ($) | ||||||
Bond Capital Fund, LP (1) | 915,369 | 17,999,999.09 | ||||||
Comcast Ventures, LP (2) | 50,853 | 999,983.57 | ||||||
Fifth Wall Ventures, L.P. (3) | 66,109 | 1,299,980.60 | ||||||
LEN FW Investor, LLC (4) | 381,403 | 7,499,984.88 | ||||||
RPM Ventures III, L.P. (5) | 50,853 | 999,983.57 |
(1) | Bond Capital Fund, LP and its affiliated funds beneficially owned (in the aggregate) more than 5% of the Old Hippo capital stock outstanding at the time of the Series E preferred stock financing. Noah Knauf is currently, and was at the time of the Series E preferred stock financing, a member of the Hippo or Old Hippo Boards of Directors and a Member of the General Partner of Bond Capital Fund, LP. |
(2) | Comcast Ventures, LP and its affiliates beneficially owned (in the aggregate) more than 5% of the Old Hippo capital stock outstanding at the time of the Series E preferred stock financing. Sam Landman is |
currently, and was at the time of the Series E preferred stock financing, a member of the Hippo or Old Hippo Boards of Directors and is no longer currently, but was at the time, a Managing Director of Comcast Ventures, LP. |
(3) | Fifth Wall Ventures, L.P. and their affiliated funds beneficially owned (in the aggregate) more than 5% of the Old Hippo capital stock outstanding at the time of the Series E preferred stock financing. |
(4) | LEN FW Investor, LLC beneficially owned more than 5% of the Old Hippo capital stock outstanding at the time of the Series E preferred financing. Eric Feder is an officer of the parent of LEN FW Investor, LLC and is currently, and was at the time of the Series E preferred stock financing, a member of Hippo’s or Old Hippo’s Board of Directors. |
(5) | RPM Ventures III, L.P. and its affiliates beneficially owned (in the aggregate) more than 5% of the Old Hippo capital stock outstanding at the time of the Series E preferred stock financing. |
• | Stock Transfer Agreement by and between Assaf Wand and the Wand Family Delaware Trust dated May 13, 2020. |
• | Stock Transfer Agreement by and between the Wand Family Delaware Trust and Bond Capital Fund, LP dated July 20, 2020. |
• | Stock Transfer Agreement by and between the Wand Family Delaware Trust and NPC Opportunity Fund dated July 20, 2020. |
• | Stock Transfer Agreement by and between the Wand Family Delaware Trust and Innovius Capital Canopus I, L.P. dated July 21, 2020. |
• | Stock Transfer Agreement by and between the Wand Family Delaware Trust and Celestial Ally Limited dated July 27, 2020. |
• | Stock Transfer Agreement by and between Ran Harpaz and Innovius Capital Canopus I, L.P. dated July 21, 2020. |
• | Stock Transfer Agreement by and between Ran Harpaz and Eric Reiner dated July 23, 2020. |
• | Stock Transfer Agreement by and between Stewart Ellis and Innovius Capital Canopus I, L.P. dated July 21, 2020. |
• | any person who is, or at any time since the beginning of Hippo’s last fiscal year was, a director or executive officer of Hippo or a nominee to become a director of Hippo; |
• | any person who is known to be the beneficial owner of more than 5% of any class of Hippo’s voting securities; |
• | any immediate family member of any of the foregoing persons, which means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, in-law orsister-in-law |
• | any firm, corporation, or other entity in which any of the foregoing persons is a partner or principal, or in a similar position, or in which such person has a 5% or greater beneficial ownership interest; and |
• | any firm, corporation, or other entity in which any director, executive officer, nominee or more than 5% beneficial owner is employed (whether or not as an executive officer). |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price of the Hippo Holdings common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which Hippo Holdings send the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like). |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” (as defined below) of Hippo Holdings common stock except as otherwise described below; |
• | if, and only if, the Reference Value (as defined above) equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like); and |
• | if the Reference Value is less than $18.00 per share (as adjusted for as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. |
Fair Market Value of Hippo Holdings Common Stock | ||||||||||||||||||||||||||||||||||||
Redemption Date (period to expiration of warrants) | ≤ 10.00 | 11.00 | 12.00 | 13.00 | 14.00 | 15.00 | 16.00 | 17.00 | ≥ 18.00 | |||||||||||||||||||||||||||
60 months | 0.261 | 0.281 | 0.297 | 0.311 | 0.324 | 0.337 | 0.348 | 0.358 | 0.361 | |||||||||||||||||||||||||||
57 months | 0.257 | 0.277 | 0.294 | 0.310 | 0.324 | 0.337 | 0.348 | 0.358 | 0.361 | |||||||||||||||||||||||||||
54 months | 0.252 | 0.272 | 0.291 | 0.307 | 0.322 | 0.335 | 0.347 | 0.357 | 0.361 | |||||||||||||||||||||||||||
51 months | 0.246 | 0.268 | 0.287 | 0.304 | 0.320 | 0.333 | 0.346 | 0.357 | 0.361 | |||||||||||||||||||||||||||
48 months | 0.241 | 0.263 | 0.283 | 0.301 | 0.317 | 0.332 | 0.344 | 0.356 | 0.361 | |||||||||||||||||||||||||||
45 months | 0.235 | 0.258 | 0.279 | 0.298 | 0.315 | 0.330 | 0.343 | 0.356 | 0.361 | |||||||||||||||||||||||||||
42 months | 0.228 | 0.252 | 0.274 | 0.294 | 0.312 | 0.328 | 0.342 | 0.355 | 0.361 |
Fair Market Value of Hippo Holdings Common Stock | ||||||||||||||||||||||||||||||||||||
Redemption Date (period to expiration of warrants) | ≤ 10.00 | 11.00 | 12.00 | 13.00 | 14.00 | 15.00 | 16.00 | 17.00 | ≥ 18.00 | |||||||||||||||||||||||||||
39 months | 0.221 | 0.246 | 0.269 | 0.290 | 0.309 | 0.325 | 0.340 | 0.354 | 0.361 | |||||||||||||||||||||||||||
36 months | 0.213 | 0.239 | 0.263 | 0.285 | 0.305 | 0.323 | 0.339 | 0.353 | 0.361 | |||||||||||||||||||||||||||
33 months | 0.205 | 0.232 | 0.257 | 0.280 | 0.301 | 0.320 | 0.337 | 0.352 | 0.361 | |||||||||||||||||||||||||||
30 months | 0.196 | 0.224 | 0.250 | 0.274 | 0.297 | 0.316 | 0.335 | 0.351 | 0.361 | |||||||||||||||||||||||||||
27 months | 0.185 | 0.214 | 0.242 | 0.268 | 0.291 | 0.313 | 0.332 | 0.350 | 0.361 | |||||||||||||||||||||||||||
24 months | 0.173 | 0.204 | 0.233 | 0.260 | 0.285 | 0.308 | 0.329 | 0.348 | 0.361 | |||||||||||||||||||||||||||
21 months | 0.161 | 0.193 | 0.223 | 0.252 | 0.279 | 0.304 | 0.326 | 0.347 | 0.361 | |||||||||||||||||||||||||||
18 months | 0.146 | 0.179 | 0.211 | 0.242 | 0.271 | 0.298 | 0.322 | 0.345 | 0.361 | |||||||||||||||||||||||||||
15 months | 0.130 | 0.164 | 0.197 | 0.230 | 0.262 | 0.291 | 0.317 | 0.342 | 0.361 | |||||||||||||||||||||||||||
12 months | 0.111 | 0.146 | 0.181 | 0.216 | 0.250 | 0.282 | 0.312 | 0.339 | 0.361 | |||||||||||||||||||||||||||
9 months | 0.090 | 0.125 | 0.162 | 0.199 | 0.237 | 0.272 | 0.305 | 0.336 | 0.361 | |||||||||||||||||||||||||||
6 months | 0.065 | 0.099 | 0.137 | 0.178 | 0.219 | 0.259 | 0.296 | 0.331 | 0.361 | |||||||||||||||||||||||||||
3 months | 0.034 | 0.065 | 0.104 | 0.150 | 0.197 | 0.243 | 0.286 | 0.326 | 0.361 | |||||||||||||||||||||||||||
0 months | — | — | 0.042 | 0.115 | 0.179 | 0.233 | 0.281 | 0.323 | 0.361 |
• | 1% of the total number of Hippo Holdings common stock then outstanding; or |
• | the average weekly reported trading volume of Hippo Holdings’ common stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. |
• | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; |
• | one or more underwritten offerings; |
• | block trades in which the broker-dealer will attempt to sell the shares of common stock or warrants as agent, but may position and resell a portion of the block as principal to facilitate the transaction; |
• | purchases by a broker-dealer as principal and resale by the broker-dealer for its accounts; |
• | an exchange distribution in accordance with the rules of the applicable exchange; |
• | privately negotiated transactions; |
• | distributions to their members, partners or shareholders; |
• | short sales effected after the date of the registration statement of which this prospectus is a part is declared effective by the SEC; |
• | through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; |
• | in market transactions, including transactions on a national securities exchange or quotations service or over-the-counter |
• | directly to one or more purchasers; |
• | through agents; |
• | broker-dealers may agree with the Selling Securityholders to sell a specified number of such shares of common stock or warrants at a stipulated price per share or warrant; and |
• | a combination of any such methods of sale. |
Page | ||||
F-2 | ||||
Consolidated Financial Statements: | ||||
F-3 | ||||
F-4 | ||||
F-5 | ||||
F-6 | ||||
F-7 |
December 31, | ||||||||
2021 | 2020 | |||||||
Assets | ||||||||
Investments: | ||||||||
Fixed maturities available-for-sale, at fair value (amortized cost: $55.6 million and $55.9 million, respectively) | $ | 54.9 | $ | 56.0 | ||||
Short-term investments | 9.1 | 0 | ||||||
Total investments | 64.0 | 56.0 | ||||||
Cash and cash equivalents | 775.6 | 452.3 | ||||||
Restricted cash | 43.1 | 40.1 | ||||||
Accounts receivable, net of allowance of $0.4 million and $0.5 million, respectively | 56.5 | 37.1 | ||||||
Reinsurance recoverable on paid and unpaid losses and LAE | 266.9 | 134.1 | ||||||
Prepaid reinsurance premiums | 231.6 | 129.4 | ||||||
Ceding commissions receivable | 41.6 | 21.3 | ||||||
Capitalized internal use software | 25.9 | 14.7 | ||||||
Goodwill | 53.5 | 47.8 | ||||||
Intangible assets | 32.2 | 33.9 | ||||||
Other assets | 51.8 | 12.7 | ||||||
Total assets | $ | 1,642.7 | $ | 979.4 | ||||
Liabilities, convertible preferred stock, and stockholders’ equity (deficit) | ||||||||
Liabilities: | ||||||||
Loss and loss adjustment expense reserve | $ | 260.8 | $ | 105.1 | ||||
Unearned premiums | 253.1 | 150.3 | ||||||
Reinsurance premiums payable | 159.4 | 86.1 | ||||||
Provision for commission | 12.3 | 28.2 | ||||||
Convertible promissory notes | 0 | 273.0 | ||||||
Derivative liability on notes | 0 | 113.3 | ||||||
Contingent consideration liability | 11.6 | 12.0 | ||||||
Preferred stock warrant liabilities | 0 | 22.9 | ||||||
Accrued expenses and other liabilities | 83.8 | 43.2 | ||||||
Total liabilities | 781.0 | 834.1 | ||||||
Commitments and contingencies (Note 15) | 0 | 0 | ||||||
Convertible preferred stock: | ||||||||
Preferred stock, $0.0001 par value per share; 10,000,000 and 323,232,460 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 0 and 305,887,443 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively; Liquidation preferences of $0 and $359.4 million as of December 31, 2021 and December 31, 2020, respectively | 0 | 344.8 | ||||||
Stockholders’ equity (deficit) | ||||||||
Common stock, $0.0001 par value per share; 2,000,000,000 and 582,981,484 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 565,031,129 and 92,547,013 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively | 0 | 0 | ||||||
Additional paid-in capital | 1,488.3 | 56.9 | ||||||
Accumulated other comprehensive (loss) income | (0.7 | ) | 0.1 | |||||
Accumulated deficit | (628.0 | ) | (256.6 | ) | ||||
Total Hippo stockholders’ equity (deficit) | 859.6 | (199.6 | ) | |||||
Noncontrolling interest | 2.1 | 0.1 | ||||||
Total stockholders’ equity (deficit) | 861.7 | (199.5 | ) | |||||
Total liabilities, convertible preferred stock, and stockholders’ equity (deficit) | $ | 1,642.7 | $ | 979.4 | ||||
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Revenue: | ||||||||
Net earned premium | $ | 38.9 | $ | 17.1 | ||||
Commission income, net | 37.5 | 27.1 | ||||||
Service and fee income | 14.5 | 6.3 | ||||||
Net investment income | 0.3 | 1.1 | ||||||
Total revenue | 91.2 | 51.6 | ||||||
Expenses: | ||||||||
Losses and loss adjustment expenses | 84.4 | 25.3 | ||||||
Insurance related expenses | 41.7 | 19.3 | ||||||
Technology and development | 36.2 | 18.0 | ||||||
Sales and marketing | 95.0 | 69.4 | ||||||
General and administrative | 49.2 | 36.8 | ||||||
Interest and other expense, net | 198.9 | 26.0 | ||||||
Gain on extinguishment of debt | (47.0 | ) | 0 | |||||
Total expenses | 458.4 | 194.8 | ||||||
Loss before income taxes | (367.2 | ) | (143.2 | ) | ||||
Income taxes expense (benefit) | 0.7 | (1.8 | ) | |||||
Net loss | (367.9 | ) | (141.4 | ) | ||||
Net income attributable to noncontrolling interests, net of tax | 3.5 | 0.1 | ||||||
Net loss attributable to Hippo | $ | (371.4 | ) | (141.5 | ) | |||
Other comprehensive loss: | ||||||||
Change in net unrealized gain or loss on investments, net of tax | (0.8 | ) | 0 | |||||
Comprehensive loss attributable to Hippo | $ | (372.2 | ) | $ | (141.5 | ) | ||
Per share data: | ||||||||
Net loss attributable to Hippo — basic and diluted | $ | (371.4 | ) | $ | (141.5 | ) | ||
Weighted-average shares used in computing net loss per share attributable to Hippo — basic and diluted | 272,168,933 | 86,897,893 | ||||||
Net loss per share attributable to Hippo — basic and diluted | $ | (1.36 | ) | $ | (1.63 | ) | ||
Convertible Preferred Stock | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Hippo Stockholders’ Equity (Deficit) | Non controlling Interests | Total Stockholders’ Equity (Deficit) | |||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||||||
Balance at January 1, 2020 | 250,604,066 | $ | 190.3 | 83,936,968 | $ | 0 | $ | 36.7 | $ | 0.1 | $ | (115.1 | ) | $ | (78.3 | ) | $ | 0 | $ | (78.3 | ) | |||||||||||||||||||
Net loss | — | — | — | — | — | — | (141.5 | ) | (141.5 | ) | 0.1 | (141.4 | ) | |||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of Series D preferred stock, net of issuance costs | 2,235,226 | 4.8 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of Series E preferred stock, net of issuance costs | 53,048,151 | 149.7 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | — | — | 8,205,205 | — | 2.5 | — | — | 2.5 | — | 2.5 | ||||||||||||||||||||||||||||||
Vesting of early exercised stock options | — | — | 269,091 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Vesting of restricted stock awards | — | — | 135,749 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | — | — | 17.7 | — | — | 17.7 | — | 17.7 | ||||||||||||||||||||||||||||||
Balance at December 31, 2020 | 305,887,443 | $ | 344.8 | 92,547,013 | $ | 0 | $ | 56.9 | $ | 0.1 | $ | (256.6 | ) | $ | (199.6 | ) | $ | 0.1 | $ | (199.5 | ) | |||||||||||||||||||
Net Loss | — | — | — | — | — | — | (371.4 | ) | (371.4 | ) | 3.5 | (367.9 | ) | |||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | (0.8 | ) | — | (0.8 | ) | — | (0.8 | ) | |||||||||||||||||||||||||||
Exercise of preferred stock warrant | 17,344,906 | 173.4 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Convertible preferred stock conversion | (323,232,349 | ) | (518.2 | ) | 323,232,349 | — | 518.2 | — | — | 518.2 | — | 518.2 | ||||||||||||||||||||||||||||
Convertible debt conversion | — | — | 43,449,312 | — | 434.5 | — | — | 434.5 | — | 434.5 | ||||||||||||||||||||||||||||||
Issuance of common stock in connection with the Business Combination, net | — | — | 54,988,620 | — | 453.9 | — | — | 453.9 | — | 453.9 | ||||||||||||||||||||||||||||||
Acquisition of public and private placement warrants | — | — | — | — | (14.6 | ) | — | — | (14.6 | ) | — | (14.6 | ) | |||||||||||||||||||||||||||
Issuance of common stock in an acquisition | — | — | 1,200,000 | — | 6.2 | — | — | 6.2 | — | 6.2 | ||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options and vesting of RSU’s | — | — | 22,089,626 | — | 5.2 | — | — | 5.2 | — | 5.2 | ||||||||||||||||||||||||||||||
Vesting of early exercised stock options | — | — | 343,370 | — | 0.8 | — | — | 0.8 | — | 0.8 | ||||||||||||||||||||||||||||||
Exercise of common stock warrants, net | — | — | 27,202,571 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Repurchase of common stock | — | — | (21,732 | ) | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | — | — | 27.2 | — | — | 27.2 | — | 27.2 | ||||||||||||||||||||||||||||||
Other | — | — | — | — | — | — | — | — | (1.5 | ) | (1.5 | ) | ||||||||||||||||||||||||||||
Balance at December 31, 2021 | 0 | $ | 0 | 565,031,129 | $ | 0 | $ | 1,488.3 | $ | (0.7 | ) | $ | (628.0 | ) | $ | 859.6 | $ | 2.1 | $ | 861.7 |
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (367.9 | ) | $ | (141.4 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 11.0 | 6.7 | ||||||
Stock–based compensation expense | 24.3 | 17.2 | ||||||
Change in fair value of preferred stock warrant liabilities | 121.6 | 16.2 | ||||||
Change in fair value of warrant liability | (10.3 | ) | 0 | |||||
Change in fair value of contingent consideration liability | 3.5 | 3.4 | ||||||
Change in fair value of derivative liability on notes | 61.4 | 6.2 | ||||||
Amortization of debt discount | 20.4 | 0 | ||||||
Gain on extinguishment of debt | (47.0 | ) | 0 | |||||
Non-cash interest expense | 5.7 | 0 | ||||||
Non-cash service expense | 7.0 | 0 | ||||||
Other non-cash items | 2.1 | 1.3 | ||||||
Changes in assets and liabilities: | ||||||||
Accounts receivable, net | (19.5 | ) | (14.7 | ) | ||||
Reinsurance recoverable on paid and unpaid losses and LAE | (132.8 | ) | (17.7 | ) | ||||
Ceding commissions receivable | (20.3 | ) | (3.4 | ) | ||||
Prepaid reinsurance premiums | (102.2 | ) | 2.5 | |||||
Other assets | (32.8 | ) | (7.8 | ) | ||||
Provision for commission | (15.9 | ) | 15.3 | |||||
Accrued expenses and other liabilities | 35.4 | 10.9 | ||||||
Loss and loss adjustment expense reserves | 155.7 | 11.8 | ||||||
Unearned premiums | 102.8 | 18.1 | ||||||
Reinsurance premiums payable | 73.3 | 10.0 | ||||||
Net cash used in operating activities | (124.5 | ) | (65.4 | ) | ||||
Cash flows from investing activities: | ||||||||
Capitalized internal use software costs | (13.3 | ) | (9.0 | ) | ||||
Purchase of intangible assets | (3.3 | ) | 0 | |||||
Purchases of property and equipment | (0.8 | ) | (0.4 | ) | ||||
Purchases of investments | (26.2 | ) | (16.7 | ) | ||||
Maturities of investments | 5.8 | 76.8 | ||||||
Sales of investments | 10.7 | 30.7 | ||||||
Cash paid for acquisitions, net of cash acquired | (0.6 | ) | (83.7 | ) | ||||
Other | (2.3 | ) | 0 | |||||
Net cash used in investing activities | (30.0 | ) | (2.3 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from Series D preferred stock, net of issuance costs | 0 | 4.9 | ||||||
Proceeds from Series E preferred stock, net of issuance costs | 0 | 149.7 | ||||||
Proceeds from the exercise of preferred stock warrants | 29.0 | 0 | ||||||
Proceeds from reverse recapitalization, net of redemptions, secondaries and costs | 450.3 | 0 | ||||||
Proceeds from exercise of options | 5.5 | 2.4 | ||||||
Payments of contingent consideration | (2.4 | ) | (3.9 | ) | ||||
Proceeds from promissory notes, net of issuance costs | 0 | 365.0 | ||||||
Other | (1.6 | ) | 0 | |||||
Net cash provided by financing activities | 480.8 | 518.1 | ||||||
Net increase in cash, cash equivalents, and restricted cash | 326.3 | 450.4 | ||||||
Cash, cash equivalents, and restricted cash at the beginning of the period | 492.4 | 42.0 | ||||||
Cash, cash equivalents, and restricted cash at the end of the period | $ | 818.7 | $ | 492.4 | ||||
Supplemental disclosures of non-cash financing and investing activities: | ||||||||
Conversion of preferred stock for common stock | $ | 518.2 | $ | 0 | ||||
Conversion of convertible notes for common stock | 434.5 | 0 | ||||||
Acquisition of public and private placement warrants | 14.6 | 0 | ||||||
Convertible promissory notes issued for services | 7.0 | 12.5 | ||||||
Equity issued for acquisitions | 6.2 | 0 |
• | Level 1 — Quoted prices in active markets for identical assets or liabilities that are publicly accessible at the measurement date. |
• | Level 2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
• | Level 3 — Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability. |
1. | Loss and loss adjustment expense paid through a given evaluation date |
2. | Case reserves for loss and loss adjustment expense for losses that have been reported but not yet paid as of a given evaluation date |
3. | IBNR for loss and loss adjustment expense include an estimate for future loss payments on incurred claims not yet reported and for expected development on reported claims |
1. | Managing General Agent (“MGA”) Commission: The Company operates as a MGA for multiple insurers. The Company designs and underwrites insurance products on behalf of the insurers culminating in the sale of insurance policies. The Company earns recurring commission and policy fees associated with the policies, they sell. While the Company has underwriting authority and responsibility for administering claims, the Company does not take the risk associated with policies on the consolidated balance sheets. Rather, the Company works with affiliated and unaffiliated carrier platforms and a diversified panel of highly rated reinsurance companies who pay the Company commission in exchange for the opportunity to take that risk on their balance sheets. The Company’s performance obligation associated with these contracts is the placement of the policy, which is met on the effective data. Upon issuance of a new policy, the Company charges policy fees and inspection fees, retains the share of ceding commission, and remits the balance of premium collected to the respective insurers. Subsequent ceding commission adjustments arising from policy changes such as endorsements, are recognized when the adjustments can be reasonably estimated. |
2. | Agency Commission: The Company also operates licensed insurance agencies that are engaged solely in the sale of policies, including non-Hippo policies. For these policies, the Company earns a recurring agency commission from the carriers whose policies the Company sells, which is recorded in the commission income, net line in the consolidated statements of operations and comprehensive loss. Similar to the MGA business, the performance obligation from the agency contracts is the placement of the insurance policies. For both MGA and insurance agency activities, the Company recognizes commission received from insurers for the sale of insurance contracts as revenue at a point in time on the policy effective dates. |
3. | Ceding Commission: The Company receives revenue based on the premium it cedes to third-party reinsurers for the compensation reimbursement for the Company’s acquisition and underwriting services. Excess ceding commission over the cost of acquisition and underwriting expenses is included in commission income, net line on the consolidated statements of operations and comprehensive loss. For the policies that the Company write on its own carrier as MGA, the Company recognizes the commission as ceding commission on the consolidated statements of operations and comprehensive loss. The Company earns commission on reinsurance premium ceded in a manner consistent with the recognition of the earned premium on the underlying insurance policies, on a pro-rata basis over the terms of the policies reinsured. The Company records the portion of ceding commission income which represents reimbursement of successful direct acquisition costs related to the underlying policies as an offset to the applicable direct acquisition costs. |
4. | Carrier Fronting Fees: Through the Company’s insurance-as-a-service business the Company earns recurring fees from the MGA programs it supports. The Company earns fronting fees in a manner consistent with the recognition of the earned premium on the underlying insurance policies, on a pro-rata basis over the terms of the policies. This revenue is included in the commission income, net line on the consolidated statements of operations and comprehensive loss. |
5. | Claim Processing Fees: As a MGA the Company receives a fee, that is calculated as a percent of the premium, from the insurers in exchange for providing claims adjudication services. The claims |
adjudication services are provided over the term of the policy and recognized ratably over the same period. |
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Net earned premium | $ | 38.9 | $ | 17.1 | ||||
Ceding commissions, net | 21.3 | 1.2 | ||||||
Agency commissions, net | 12.3 | 8.4 | ||||||
Policy fees | 10.9 | 2.6 | ||||||
MGA commissions, net | 2.6 | 12.8 | ||||||
Claims processing fees | 1.3 | 4.6 | ||||||
Other revenue | 3.6 | 3.8 | ||||||
Net investment income | 0.3 | 1.1 | ||||||
Total revenue, net | $ | 91.2 | $ | 51.6 | ||||
• | Certain accredited investors (the “PIPE Investors”) entered into subscription agreements (the “PIPE Subscription Agreements”) pursuant to which the PIPE Investors agreed to purchase 55,000,000 shares (the “PIPE Shares”) of the Company’s common stock at a purchase price per share of $10.00 and an aggregate purchase price of $550.0 million (the “PIPE Investment”). The PIPE Investment was consummated concurrently with the Closing. |
• | Hippo used $95.0 million to reacquire 9,500,000 shares of common stock from certain stockholders of Old Hippo prior to the Business Combination. |
• | Prior to the Business Combination, RTPZ issued an aggregate of 5,750,000 shares of Class B common stock (the “Founder Shares”) to Reinvent Sponsor Z LLC, a Cayman Islands limited liability company (the “Sponsor”) for an aggregate purchase price of $25,000 in cash. All outstanding Founder Shares were automatically converted into shares of the Company’s common stock on a 1-for-one basis at the Closing and will continue to be subject to the transfer restrictions applicable to such Founder Shares. |
• | Prior to the Closing, holders of 19,261,380 shares of Class A common stock of RTPZ exercised their rights to redeem those shares for cash at an approximate price of $10.00 per share, for an aggregate of approximately $192.6 million which was paid to such holders at Closing. The remaining Class A common stock of RTPZ converted into shares of the Company’s common stock on a 1-for-one basis at the Closing. |
• | Immediately after giving effect to the Merger and the PIPE Investment, there were 559,731,226 shares of Hippo common stock outstanding. |
in millions | Recapitalization | |||
Cash in trust, net of redemptions | $ | 37.7 | ||
Cash — PIPE | 550.0 | |||
Less: Cash used for repurchase of common stock | (95.0 | ) | ||
Less: transaction costs and advisory fees | (42.4 | ) | ||
Net cash received from the Business Combination and PIPE investment | $ | 450.3 | ||
Net assets acquired from the Business Combination | 3.6 | |||
Total | $ | 453.9 | ||
Number of Shares | ||||
Class A common stock outstanding prior to Business Combination | 23,000,000 | |||
Less: Redemption of RTPZ Class A common stock | (19,261,380 | ) | ||
Class A common stock of RTPZ | 3,738,620 | |||
RTPZ Founder shares — Class B | 5,750,000 | |||
PIPE Shares | 55,000,000 | |||
Business Combination and PIPE shares which converted to Hippo common stock | 64,488,620 | |||
Old Hippo shares, net of repurchase (1) | 495,242,606 | |||
Total shares of common stock outstanding immediately after Business Combination and PIPE investment | 559,731,226 |
(1) | The number of Old Hippo shares was determined based on Old Hippo common stock outstanding immediately prior to the closing of the Business Combination multiplied by the Exchange Ratio of 6.95433 adjusted for buyback of 9,500,000 shares of common stock. For further details, refer to Note 17, Stockholders’ Equity. |
December 31, 2021 | ||||||||||||||||
Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | |||||||||||||
Fixed maturities available-for-sale: | ||||||||||||||||
U.S. government and agencies | $ | 9.3 | $ | 0 | $ | 0 | $ | 9.3 | ||||||||
States, and other territories | 5.8 | 0 | (0.1 | ) | 5.7 | |||||||||||
Corporate securities | 17.3 | 0 | (0.2 | ) | 17.1 | |||||||||||
Foreign securities | 0.9 | 0 | 0 | 0.9 | ||||||||||||
Residential mortgage-backed securities | 10.8 | 0 | (0.2 | ) | 10.6 | |||||||||||
Commercial mortgage-backed securities | 4.8 | 0 | (0.1 | ) | 4.7 | |||||||||||
Asset backed securities | 6.7 | 0 | (0.1 | ) | 6.6 | |||||||||||
Total fixed maturities available-for-sale | 55.6 | 0 | (0.7 | ) | 54.9 | |||||||||||
Short-term investments: | ||||||||||||||||
U.S. government and agencies | 9.1 | 0 | 0 | 9.1 | ||||||||||||
Total | $ | 64.7 | $ | 0 | $ | (0.7 | ) | $ | 64.0 | |||||||
December 31, 2020 | ||||||||||||||||
Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | |||||||||||||
Fixed maturities available-for-sale: | ||||||||||||||||
U.S. government and agencies | $ | 10.1 | $ | 0 | $ | 0 | $ | 10.1 | ||||||||
States, and other territories | 5.1 | 0 | 0 | 5.1 | ||||||||||||
Corporate securities | 17.4 | 0 | 0 | 17.4 | ||||||||||||
Foreign securities | 0.8 | 0 | 0 | 0.8 | ||||||||||||
Residential mortgage-backed securities | 12.9 | 0 | 0 | 12.9 | ||||||||||||
Commercial mortgage-backed securities | 5.4 | 0.1 | 0 | 5.5 | ||||||||||||
Asset backed securities | 4.2 | 0 | 0 | 4.2 | ||||||||||||
Total | $ | 55.9 | $ | 0.1 | $ | 0 | $ | 56.0 | ||||||||
December 31, 2021 | ||||||||
Amortized Cost | Fair Value | |||||||
Due to mature: | ||||||||
One year or less | $ | 10.5 | $ | 10.5 | ||||
After one year through five years | 18.3 | 18.1 | ||||||
After five years | 4.5 | 4.4 | ||||||
Residential mortgage-backed securities | 10.8 | 10.6 | ||||||
Commercial mortgage-backed securities | 4.8 | 4.7 | ||||||
Asset backed securities | 6.7 | 6.6 | ||||||
Total fixed maturities available-for-sale | $ | 55.6 | $ | 54.9 | ||||
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Fixed maturities income | $ | 0.4 | $ | 1.1 | ||||
Short-term investment income | 0 | 0 | ||||||
Total gross investment income | 0.4 | 1.1 | ||||||
Investment expenses | (0.1 | ) | 0 | |||||
Net investment income | $ | 0.3 | $ | 1.1 | ||||
December 31, 2021 | December 31, 2020 | |||||||||||||||
Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||
State | ||||||||||||||||
New York | $ | 3.2 | $ | 3.2 | $ | 3.1 | $ | 3.1 | ||||||||
Illinois | 1.9 | 1.9 | 1.6 | 1.6 | ||||||||||||
Colorado | 1.4 | 1.5 | 1.5 | 1.5 | ||||||||||||
Virginia | 0.3 | 0.4 | 0.4 | 0.4 | ||||||||||||
North Carolina | 0.3 | 0.3 | 0.3 | 0.3 | ||||||||||||
New Mexico | 0.3 | 0.3 | 0.4 | 0.4 | ||||||||||||
Vermont | 0.3 | 0.3 | 0.3 | 0.3 | ||||||||||||
Florida | 0.3 | 0.3 | 0.3 | 0.3 | ||||||||||||
Nevada | 0.2 | 0.2 | 0.4 | 0.4 | ||||||||||||
Massachusetts | 0.1 | 0.1 | 0.1 | 0.1 | ||||||||||||
Georgia | 0.1 | 0.1 | 0 | 0 | ||||||||||||
Total states | $ | 8.4 | $ | 8.6 | $ | 8.4 | $ | 8.4 | ||||||||
December 31, 2021 | December 31, 2020 | |||||||
Cash and cash equivalents: | ||||||||
Cash | $ | 219.2 | $ | 56.7 | ||||
Money market funds | 556.4 | 372.1 | ||||||
Treasury bills | 0 | 23.5 | ||||||
Total cash and cash equivalents | 775.6 | 452.3 | ||||||
Restricted cash: | ||||||||
Fiduciary assets | 25.0 | 12.1 | ||||||
Letters of credit and cash on deposit | 18.1 | 28.0 | ||||||
Total restricted cash | 43.1 | 40.1 | ||||||
Total cash, cash equivalents, and restricted cash | $ | 818.7 | $ | 492.4 | ||||
December 31, 2021 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Financial assets: | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market funds | $ | 556.4 | $ | 0 | $ | 0 | $ | 556.4 | ||||||||
Total cash equivalents | 556.4 | 0 | 0 | 556.4 | ||||||||||||
Fixed maturities available-for-sale: | ||||||||||||||||
U.S. government and agencies | 9.3 | 0 | 0 | 9.3 | ||||||||||||
States, and other territories | 0 | 5.7 | 0 | 5.7 | ||||||||||||
Corporate securities | 0 | 17.1 | 0 | 17.1 | ||||||||||||
Foreign securities | 0 | 0.9 | 0 | 0.9 | ||||||||||||
Residential mortgage-backed securities | 0 | 10.6 | 0 | 10.6 | ||||||||||||
Commercial mortgage-backed securities | 0 | 4.7 | 0 | 4.7 | ||||||||||||
Asset backed securities | 0 | 6.6 | 0 | 6.6 | ||||||||||||
Total fixed maturities available-for-sale | 9.3 | 45.6 | 0 | 54.9 | ||||||||||||
Short term investments | ||||||||||||||||
U.S. government and agencies | 0 | 9.1 | 0 | 9.1 | ||||||||||||
Total financial assets | $ | 565.7 | $ | 54.7 | $ | 0 | $ | 620.4 | ||||||||
Financial liabilities: | ||||||||||||||||
Contingent consideration liability | $ | 0 | $ | 0 | $ | 11.6 | $ | 11.6 | ||||||||
Public warrants | 2.2 | 0 | 0 | 2.2 | ||||||||||||
Private placement warrants | 0 | 2.1 | 0 | 2.1 | ||||||||||||
Total financial liabilities | $ | 2.2 | $ | 2.1 | $ | 11.6 | $ | 15.9 | ||||||||
December 31, 2020 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Financial assets: | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market funds | $ | 372.1 | $ | 0 | $ | 0 | $ | 372.1 | ||||||||
Treasury bills | 23.5 | 0 | 0 | 23.5 | ||||||||||||
Total cash equivalents | 395.6 | 0 | 0 | 395.6 | ||||||||||||
Fixed maturities available-for-sale: | ||||||||||||||||
U.S. government and agencies | 10.1 | 0 | 0 | 10.1 | ||||||||||||
States, and other territories | 0 | 5.1 | 0 | 5.1 | ||||||||||||
Corporate securities | 0 | 17.4 | 0 | 17.4 | ||||||||||||
Foreign securities | 0 | 0.8 | 0 | 0.8 | ||||||||||||
Residential mortgage-backed securities | 0 | 12.9 | 0 | 12.9 | ||||||||||||
Commercial mortgage-backed securities | 0 | 5.5 | 0 | 5.5 | ||||||||||||
Asset backed securities | 0 | 4.2 | 0 | 4.2 | ||||||||||||
Total fixed maturities available-for-sale | 10.1 | 45.9 | 0 | 56.0 | ||||||||||||
Total financial assets | $ | 405.7 | $ | 45.9 | $ | 0 | $ | 451.6 | ||||||||
Financial liabilities: | ||||||||||||||||
Derivative liability on convertible promissory notes | $ | 0 | $ | 0 | $ | 113.3 | $ | 113.3 | ||||||||
Contingent consideration liability | 0 | 0 | 12.0 | 12.0 | ||||||||||||
Preferred stock warrant liabilities | 0 | 0 | 22.9 | 22.9 | ||||||||||||
Total financial liabilities | $ | 0 | $ | 0 | $ | 148.2 | $ | 148.2 | ||||||||
2021 | 2020 | |||||||
Balance as of January 1, | $ | 22.9 | $ | 6.7 | ||||
Changes in fair value | 121.6 | 16.2 | ||||||
Settlement of preferred stock warrants | (144.5 | ) | 0 | |||||
Balance as of December 31, | $ | 0 | $ | 22.9 | ||||
2021 | 2020 | |||||||
Balance as of January 1, | $ | 12.0 | $ | 13.8 | ||||
Payments of contingent consideration | (3.9 | ) | (5.2 | ) | ||||
Changes in fair value | 3.5 | 3.4 | ||||||
Balance as of December 31, | $ | 11.6 | $ | 12.0 | ||||
2021 | 2020 | |||||||
Balance as of January 1, | $ | 113.3 | $ | 0 | ||||
Initial measurement of new derivative | 2.8 | 107.2 | ||||||
Changes in fair value | 61.4 | 6.1 | ||||||
Settlement of derivative liability | (177.5 | ) | 0 | |||||
Balance as of December 31, | $ | 0 | $ | 113.3 | ||||
2021 | ||||
Balance as of January 1, | $ | 0 | ||
Initial measurement of warrants | 14.6 | |||
Changes in fair value | (10.3 | ) | ||
Balance as of December 31, | $ | 4.3 | ||
Balance at January 1, 2020 | $ | 1.9 | ||
Additions from acquisitions | 45.9 | |||
Balance at December 31, 2020 | $ | 47.8 | ||
Additions from acquisitions | 5.2 | |||
Other adjustments | 0.5 | |||
Balance at December 31, 2021 | $ | 53.5 | ||
December 31, 2021 | December 31, 2020 | |||||||||||||||||||||||||||
Weighted- Average Useful Life Remaining (in years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||||||
(in millions) | (in millions) | |||||||||||||||||||||||||||
Agency and carrier relationships | 6.9 | $ | 13.5 | $ | (1.7 | ) | $ | 11.8 | $ | 13.5 | $ | (0.1 | ) | $ | 13.4 | |||||||||||||
State licenses and domain name | Indefinite | 10.5 | — | 10.5 | 7.1 | — | 7.1 | |||||||||||||||||||||
Customer relationships | 3.2 | 13.7 | (6.0 | ) | 7.7 | 13.2 | (3.8 | ) | 9.4 | |||||||||||||||||||
Developed technology | 0.3 | 3.6 | (2.7 | ) | 0.9 | 3.6 | (1.4 | ) | 2.2 | |||||||||||||||||||
VOBA | 0.7 | 0.1 | (0.1 | ) | — | 0.1 | — | 0.1 | ||||||||||||||||||||
Other | 6.5 | 2.0 | (0.7 | ) | 1.3 | 1.9 | (0.2 | ) | 1.7 | |||||||||||||||||||
Total intangible assets, net | $ | 43.4 | $ | (11.2 | ) | $ | 32.2 | $ | 39.4 | $ | (5.5 | ) | $ | 33.9 | ||||||||||||||
Year ending December 31, | ||||
2022 | $ | 5.2 | ||
2023 | 4.2 | |||
2024 | 4.0 | |||
2025 | 2.4 | |||
2026 | 1.7 | |||
Thereafter | 4.2 | |||
Total | $ | 21.7 | ||
December 31, 2021 | December 31, 2020 | |||||||
(in millions) | ||||||||
Capitalized internal use software | $ | 34.5 | $ | 18.4 | ||||
Less: accumulated amortization | (8.6 | ) | (3.7 | ) | ||||
Total capitalized internal use software | $ | 25.9 | $ | 14.7 | ||||
December 31, 2021 | December 31, 2020 | |||||||
(in millions) | ||||||||
Claim payments outstanding | $ | 23.2 | $ | 9.9 | ||||
Deferred revenue | 11.2 | 1.7 | ||||||
Advances from customers | 8.7 | 4.4 | ||||||
Employee related accruals | 8.5 | 5.0 | ||||||
Accrued licenses and taxes | 5.8 | 2.5 | ||||||
Premium refund liability | 4.8 | 2.6 | ||||||
Warrant liability | 4.3 | 0 | ||||||
Fiduciary liability | 3.7 | 5.0 | ||||||
Other | 13.6 | 12.1 | ||||||
Total accrued expenses and other liabilities | $ | 83.8 | $ | 43.2 | ||||
2021 | 2020 | |||||||
Reserve for losses and LAE gross of reinsurance recoverables on unpaid losses and LAE as of beginning of the period | $ | 105.1 | $ | 0 | ||||
Reinsurance recoverables on unpaid losses | (92.1 | ) | 0 | |||||
Reserve for losses and LAE, net of reinsurance recoverables as of beginning of the period | 13.0 | 0 | ||||||
Add: Incurred losses and LAE, net of reinsurance, related to: | ||||||||
Current year | 85.0 | 25.3 | ||||||
Prior years | (0.6 | ) | 0 | |||||
Total incurred | 84.4 | 25.3 | ||||||
Deduct: Loss and LAE payments, net of reinsurance, related to: | ||||||||
Current year | 43.6 | 17.0 | ||||||
Prior year | 9.8 | 0.3 | ||||||
Total paid | 53.4 | 17.3 | ||||||
Reserve for losses and LAE, net of reinsurance recoverables acquired from Spinnaker | 0 | 5.0 | ||||||
Reserve for losses and LAE, net of reinsurance recoverables at end of period | 44.0 | 13.0 | ||||||
Add: Reinsurance recoverables on unpaid losses and LAE at end of period | 216.8 | 92.1 | ||||||
Reserve for losses and LAE gross of reinsurance recoverables on unpaid losses and LAE as of end of the period | $ | 260.8 | $ | 105.1 | ||||
December 31, | December 31, 2021 | |||||||||||||||||||||||||||||||||||
2015* | 2016* | 2017* | 2018* | 2019* | 2020* | 2021 | IBNR | Cumulative Number of Reported Claims | ||||||||||||||||||||||||||||
Accident Year | ||||||||||||||||||||||||||||||||||||
2015 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | 7 | |||||||||||||||||||
2016 | 2.5 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 0 | 715 | ||||||||||||||||||||||||||||
2017 | 5.2 | 4.4 | 4.0 | 4.0 | 4.0 | 0 | 3,072 | |||||||||||||||||||||||||||||
2018 | 7.8 | 7.2 | 7.2 | 7.2 | 0.5 | 5,882 | ||||||||||||||||||||||||||||||
2019 | 4.8 | 4.9 | 4.7 | 0 | 14,952 | |||||||||||||||||||||||||||||||
2020 | 28.1 | 27.7 | 1.5 | 28,304 | ||||||||||||||||||||||||||||||||
2021 | 76.7 | 32.1 | 38,903 | |||||||||||||||||||||||||||||||||
Total incurred Loss and Loss Adjustment Expenses, net | $ | 122.1 | $ | 34.1 | 91,835 | |||||||||||||||||||||||||||||||
* | Presented as unaudited required supplementary information |
December 31, | ||||||||||||||||||||||||||||
2015* | 2016* | 2017* | 2018* | 2019* | 2020* | 2021 | ||||||||||||||||||||||
Accident Year | ||||||||||||||||||||||||||||
2015 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||
2016 | 1.2 | 1.8 | 1.9 | 1.8 | 1.8 | 1.8 | ||||||||||||||||||||||
2017 | 3.0 | 4.0 | 4.0 | 4.0 | 4.0 | |||||||||||||||||||||||
2018 | 5.3 | 5.7 | 5.7 | 5.7 | ||||||||||||||||||||||||
2019 | 3.2 | 4.4 | 4.6 | |||||||||||||||||||||||||
2020 | 17.1 | 26.8 | ||||||||||||||||||||||||||
2021 | 35.2 | |||||||||||||||||||||||||||
Total paid losses and LAE, net | $ | 78.1 | ||||||||||||||||||||||||||
Total unpaid loss and LAE reserves, net | 44.0 | |||||||||||||||||||||||||||
Ceded unpaid loss and LAE | $ | 216.8 | ||||||||||||||||||||||||||
Gross unpaid loss and LAE | $ | 260.8 | ||||||||||||||||||||||||||
* | Presented as unaudited required supplementary information |
Years | 1 | 2 | 3 | 4 | 5 | |||||||||||||||
Property and Casualty | 81 | % | 12 | % | 3 | % | 3 | % | 2 | % |
2021 Current Accident Year | ||||||||
Incurred | Paid | |||||||
Development table | $ | 76.7 | $ | 35.2 | ||||
Unallocated loss adjustment expense | 8.3 | 8.3 | ||||||
Other | 0 | 0.1 | ||||||
Rollforward table | $ | 85.0 | $ | 43.6 | ||||
2020 Current Accident Year | ||||||||
Incurred | Paid | |||||||
Development table | $ | 28.1 | $ | 17.1 | ||||
Unallocated loss adjustment expense | 2.2 | (2.1 | ) | |||||
Loss and LAE of Spinnaker prior to the acquisition | (5.0 | ) | 2.0 | |||||
Rollforward table | $ | 25.3 | $ | 17.0 | ||||
As of December 31, | ||||||||||||||||
2021 | 2020 | |||||||||||||||
Loss and LAE Reserve | Unearned premiums | Loss and LAE Reserve | Unearned premiums | |||||||||||||
Direct | $ | 253.4 | $ | 246.6 | $ | 102.7 | $ | 143.7 | ||||||||
Assumed | 7.4 | 6.5 | 2.4 | 6.6 | ||||||||||||
Gross | 260.8 | 253.1 | 105.1 | 150.3 | ||||||||||||
Ceded | (216.8 | ) | (231.6 | ) | (92.1 | ) | (129.4 | ) | ||||||||
Net | $ | 44.0 | $ | 21.5 | $ | 13.0 | $ | 20.9 | ||||||||
For the Year Ended December 31, | ||||||||||||||||||||||||
2021 | 2020 | |||||||||||||||||||||||
Written premiums | Earned premiums | Loss and LAE incurred | Written premiums | Earned premiums | Loss and LAE incurred | |||||||||||||||||||
Direct | $ | 474.0 | $ | 364.7 | $ | 498.5 | $ | 90.0 | $ | 88.7 | $ | 93.6 | ||||||||||||
Assumed | 3.3 | 9.8 | 16.9 | 26.1 | 9.3 | 13.3 | ||||||||||||||||||
Gross | 477.3 | 374.5 | 515.4 | 116.1 | 98.0 | 106.9 | ||||||||||||||||||
Ceded | (434.8 | ) | (335.6 | ) | (431.0 | ) | (78.4 | ) | (80.9 | ) | (81.6 | ) | ||||||||||||
Net | $ | 42.5 | $ | 38.9 | $ | 84.4 | $ | 37.7 | $ | 17.1 | $ | 25.3 | ||||||||||||
December 31, | ||||||||
2021 | 2020 | |||||||
Reinsurance recoverable on paid loss | $ | 50.1 | $ | 42.0 | ||||
Ceded unpaid loss and LAE | 216.8 | 92.1 | ||||||
Total reinsurance recoverable | $ | 266.9 | $ | 134.1 | ||||
December 31, | ||||||||||
AM Best Rating | Reinsurer | 2021 | 2020 | |||||||
A+ | Everest Insurance Company | $ | 65.7 | $ | 4.2 | |||||
A | Validus Reinsurance (Switzerland) Ltd. | 57.5 | 22.6 | |||||||
A+ | Transatlantic Reinsurance Company | 46.3 | 28.8 | |||||||
A+ | Renaissance Reinsurance U.S. Inc. | 28.9 | 5.5 | |||||||
A+ | Munich Reinsurance America, Inc. | 18.3 | 11.7 | |||||||
A | Validus Reinsurance, Ltd. | 9.6 | 46.9 | |||||||
A++ | General Reinsurance Corporation | 7.9 | 14.4 | |||||||
$ | 234.2 | $ | 134.1 | |||||||
Other reinsurers | 86.9 | 28.4 | ||||||||
$ | 321.1 | $ | 162.5 | |||||||
Year Ended December 31, | ||||||||||||||||
2021 | 2020 | |||||||||||||||
Amount | % of GWP | Amount | % of GWP | |||||||||||||
State | ||||||||||||||||
Texas | $ | 139.2 | 29.2 | % | $ | 43.9 | 37.8 | % | ||||||||
California | 85.2 | 17.9 | % | 10.4 | 9.0 | % | ||||||||||
Florida | 26.8 | 5.6 | % | 7.3 | 6.3 | % | ||||||||||
Georgia | 22.0 | 4.6 | % | 4.7 | 4.0 | % | ||||||||||
Illinois | 19.1 | 4.0 | % | 4.9 | 4.2 | % | ||||||||||
Colorado | 13.6 | 2.8 | % | 2.5 | 2.2 | % | ||||||||||
Missouri | 13.0 | 2.7 | % | 3.4 | 2.9 | % | ||||||||||
Arizona | 11.4 | 2.4 | % | 1.6 | 1.4 | % | ||||||||||
Ohio | 10.5 | 2.2 | % | 3.0 | 2.6 | % | ||||||||||
New Jersey | 10.4 | 2.2 | % | 3.4 | 2.9 | % | ||||||||||
Other | 126.1 | 26.4 | % | 31.0 | 26.7 | % | ||||||||||
Total | $ | 477.3 | 100 | % | $ | 116.1 | 100 | % | ||||||||
Year ending December 31, | ||||
2022 | $ | 4.1 | ||
2023 | 5.1 | |||
2024 | 5.2 | |||
2025 | 5.2 | |||
2026 | 4.2 | |||
Thereafter | 5.2 | |||
Total | $ | 29.0 | ||
December 31, 2020 | ||||||||||||||||||||
Issuance Price Per Share | Authorized Shares | Shares Issued and Outstanding | Net Carrying Value | Liquidation Preference | ||||||||||||||||
Preferred A-1 Stock | $ | 0.56965 | 40,959,815 | 40,959,815 | $ | 3.4 | $ | 3.4 | ||||||||||||
Preferred A-2 Stock | 1.57432 | 48,790,097 | 48,590,772 | 10.9 | 11.0 | |||||||||||||||
Preferred B Stock | 3.59757 | 48,326,627 | 48,326,627 | 24.9 | 25.0 | |||||||||||||||
Preferred C Stock | 7.04471 | 69,101,902 | 69,101,895 | 56.1 | 70.0 | |||||||||||||||
Preferred C-1 Stock | 11.74119 | 17,145,581 | 0 | 0 | 0 | |||||||||||||||
Preferred D Stock | 15.16420 | 45,860,183 | 45,860,183 | 99.8 | 100.0 | |||||||||||||||
Preferred E Stock | 19.66420 | 53,048,255 | 53,048,151 | 149.7 | 150.0 | |||||||||||||||
Total | 323,232,460 | 305,887,443 | $ | 344.8 | $ | 359.4 | ||||||||||||||
December 31, 2020 | ||
Fair value of Series A-2 Preferred Stock | $18.25 | |
Fair value of Series C-1 Preferred Stock | $20.09 | |
Exercise price A-2 Preferred Stock | $1.57 | |
Exercise price C-1 Preferred Stock | $11.74 | |
Expected term (in years) | 1.8-6.2 | |
Expected volatility | 29.0%-40.7% | |
Risk-free interest rate | 0.1%-0.5% | |
Expected dividend yield | 0% |
Description | Balance outstanding prior to the Business Combination | Exchange Ratio | Post Conversion Balances | |||||||||
Old Hippo common stock | 15,940,914 | 6.95433 | 110,858,374 | |||||||||
Old Hippo convertible preferred stock | 43,985,178 | 6.95433 | 305,887,443 | |||||||||
Old Hippo convertible promissory notes | 6,247,807 | 6.95433 | 43,449,312 | |||||||||
Old Hippo preferred stock warrants | 2,494,116 | 6.95433 | 17,344,906 | |||||||||
Old Hippo common stock warrants | 3,911,610 | 6.95433 | 27,202,571 | |||||||||
504,742,606 | ||||||||||||
Less: Repurchase of common stock | (9,500,000 | ) | ||||||||||
Net Old Hippo shares consideration | 495,242,606 | |||||||||||
Issue Date | Exercise Price Per Share | Number of Warrants | Expiration Date | Outstanding as of December 31, 2020 | ||||||||||
December 11, 2017 | $ | 0.01 | 4,738,051 | December 31, 2022 | 4,738,051 | |||||||||
February 19, 2018 | $ | 0.01 | 4,738,051 | August 19, 2022 | 4,738,051 |
Options Outstanding | Weighted-Average Remaining Contract Term (In Years) | Aggregate Intrinsic Value (In Millions) | ||||||||||||||
Number of Shares | Weighted Average Exercise Price | |||||||||||||||
Outstanding as of January 1, 2021 | 72,205,242 | $ | 0.70 | 8.90 | $ | 108.9 | ||||||||||
Granted | 9,686,589 | 4.81 | ||||||||||||||
Exercised | (22,801,742 | ) | 0.33 | |||||||||||||
Cancelled/Expired | (11,551,163 | ) | 2.05 | |||||||||||||
Outstanding as of December 31, 2021 | 47,538,926 | $ | 1.39 | 8.30 | $ | 84.8 | ||||||||||
Vested and exercisable as of December 31, 2021 | 15,919,802 | $ | 0.81 | 7.88 | $ | 32.9 | ||||||||||
December 31, | ||||||||
2021 | 2020 | |||||||
Expected term (in years) | 5.4 - 6.5 | 5.6 - 6.1 | ||||||
Expected volatility | 29.6% - 30.1% | 22.6% - 29.9% | ||||||
Risk-free interest rate | 0.6% - 1.4% | 0.3% - 1.6% | ||||||
Expected dividend yield | 0 % | 0 % |
Number of Shares | Weighted Average Grant-Date Fair Value per Share | |||||||
Unvested and outstanding as of December 31, 2020 | 0 | $ | 0 | |||||
Granted | 28,233,515 | 3.91 | ||||||
Vested | (187,125 | ) | 4.00 | |||||
Canceled and forfeited | (875,460 | ) | 3.97 | |||||
Unvested and outstanding as of December 31, 2021 | 27,170,930 | 3.91 | ||||||
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Losses and loss adjustment expenses | $ | 0.6 | $ | 0.1 | ||||
Insurance related expenses | 1.1 | 0.2 | ||||||
Technology and development | 6.8 | 2.4 | ||||||
Sales and marketing | 5.0 | 2.1 | ||||||
General and administrative | 10.8 | 12.4 | ||||||
Total stock-based compensation expense | $ | 24.3 | $ | 17.2 | ||||
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
United States | $ | (371.3 | ) | $ | (143.2 | ) | ||
Foreign | 0.6 | 0 | ||||||
Total | $ | (370.7 | ) | $ | (143.2 | ) | ||
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Loss before income taxes | $ | (370.7 | ) | $ | (143.2 | ) | ||
Income tax benefit from statutory rate | (77.9 | ) | (30.1 | ) | ||||
Effect of: | ||||||||
Meals, entertainment & parking | 0.1 | 0.1 | ||||||
Deferred compensation | 27.8 | 8.1 | ||||||
Transaction costs | 0.1 | 0.1 | ||||||
State taxes | (7.2 | ) | (1.1 | ) | ||||
Non-deductible interest | 5.5 | 0 | ||||||
Increase in valuation allowance | 53.4 | 19.9 | ||||||
Other | (1.1 | ) | 1.2 | |||||
Income taxes expense (benefit) | $ | 0.7 | $ | (1.8 | ) | |||
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Income tax applicable to: | ||||||||
Current | ||||||||
State | $ | 0.2 | $ | 0.2 | ||||
Foreign | 0.5 | 0 | ||||||
Total current provision | $ | 0.7 | $ | 0.2 | ||||
Deferred | ||||||||
Federal | $ | 0 | $ | (1.9 | ) | |||
State | 0 | (0.1 | ) | |||||
Total deferred provision | $ | 0 | $ | (2.0 | ) | |||
Total provision for income taxes | $ | 0.7 | $ | (1.8 | ) | |||
As of December 31, | ||||||||
2021 | 2020 | |||||||
Deferred tax assets: | ||||||||
Net operating loss carryforward | $ | 87.4 | $ | 35.4 | ||||
Provision for commission | 0 | 5.4 | ||||||
Intangible assets | 3.5 | 3.1 | ||||||
Research and development credit | 2.4 | 0.2 | ||||||
Deferred compensation | 2.2 | 0.3 | ||||||
Unearned premium reserve | 1.2 | 1.0 | ||||||
Loss reserve discount | 0.6 | 0.1 | ||||||
Unrealized losses | 0.2 | 0 | ||||||
Deferred rent | 0.2 | 0.1 | ||||||
Other accruals | 3.5 | 0.9 | ||||||
Interest expense limitation | 0 | 0.6 | ||||||
Total deferred tax assets | $ | 101.2 | $ | 47.1 | ||||
Valuation allowance | (93.2 | ) | (39.6 | ) | ||||
Total deferred income tax assets | $ | 8.0 | $ | 7.5 | ||||
Deferred tax liabilities | ||||||||
Property and equipment | $ | 0.3 | $ | 0.1 | ||||
Provision for commission | 0.2 | 0 | ||||||
Capitalized software | 6.1 | 3.3 | ||||||
Acquired intangibles | 0.2 | 0.5 | ||||||
Unrealized gains | 0 | 0.4 | ||||||
Spinnaker stepped-up adjustment | 0 | 2.9 | ||||||
Deferred acquisition costs | 0.9 | 0.3 | ||||||
Other | 0.3 | 0 | ||||||
Total deferred tax liabilities | $ | 8.0 | $ | 7.5 | ||||
Deferred income tax assets, net | $ | 0 | $ | 0 | ||||
20-year Carryforward Expires in 2035 - 2041 | Indefinite Carryforward Period | Total | ||||||||||
U.S. Federal | $ | 62.4 | $ | 310.5 | $ | 372.9 | ||||||
U.S. State | 136.3 | 0 | 136.3 | |||||||||
Balance as of December 31, 2021 | $ | 198.7 | $ | 310.5 | $ | 509.2 | ||||||
Year Ended December 31, | ||||||||
2021 | 2020 | |||||||
Numerator: | ||||||||
Net loss attributable to Hippo – basic and diluted (in millions) | $ | (371.4 | ) | $ | (141.5 | ) | ||
Denominator: | ||||||||
Weighted-average shares used in computing net loss per share attributable to Hippo — basic and diluted | 272,168,933 | 86,897,893 | ||||||
Net loss per share attributable to Hippo — basic and diluted | $ | (1.36 | ) | $ | (1.63 | ) | ||
December 31, | ||||||||
2021 | 2020 | |||||||
Convertible preferred stock (on an as if converted basis) | 0 | 275,009,550 | ||||||
Outstanding options | 47,538,926 | 58,168,262 | ||||||
Warrants to purchase common shares | 9,000,000 | 33,127,646 | ||||||
Warrants to purchase preferred shares | 0 | 17,344,906 | ||||||
Common stock subject to repurchase | 5,008,767 | 9,499,253 | ||||||
RSU and PRSUs | 28,939,349 | 0 | ||||||
Convertible notes | 0 | 15,146,260 | ||||||
Total | 90,487,042 | 408,295,877 | ||||||
Fair value of Consideration Transferred | ||||
Cash paid | $ | 95.6 | ||
Less: consideration for settlement of pre-existing liability due to Spinnaker | (5.1 | ) | ||
Total value of consideration transferred | $ | 90.5 | ||
Acquisition-Date Fair Value | Estimated Useful Life of Finite-Lived Intangible Assets | |||||||
Tangible assets acquired and (liabilities) assumed: | ||||||||
Investments: | ||||||||
Fixed maturities available-for-sale, at fair value | $ | 45.7 | ||||||
Short term investments | 5.0 | |||||||
Total investments | $ | 50.7 | ||||||
Cash and cash equivalents | 16.9 | |||||||
Restricted cash | 2.1 | |||||||
Accounts receivable, net | 18.3 | |||||||
Reinsurance recoverable on paid and unpaid losses and LAE | 116.3 | |||||||
Ceding commissions receivable | 18.7 | |||||||
Prepaid reinsurance premiums | 131.9 | |||||||
Other assets | 0.6 | |||||||
Accrued expenses and other liabilities | (6.6 | ) | ||||||
Loss and loss adjustment expense reserves | (93.3 | ) | ||||||
Unearned premiums | (132.1 | ) | ||||||
Reinsurance premium payable | (76.1 | ) | ||||||
Net tangible assets acquired | $ | 47.4 | ||||||
Intangible assets acquired | ||||||||
Agency relationships | 3.4 | 8 years | ||||||
VOBA | 0.1 | 2 years | ||||||
State licenses | 7.1 | Indefinite | ||||||
Goodwill | 32.5 | |||||||
Total purchase price | $ | 90.5 |
Year Ended December 31, 2020 | ||||
Pro forma revenue | $ | 54.1 | ||
Pro forma net loss | $ | (136.6 | ) |
Statutory Net Income | Capital Surplus | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Statutory net income | ||||||||||||||||
U.S. insurance subsidiaries | $ | (0.5 | ) | $ | 6.6 | $ | 131.8 | $ | 69.6 | |||||||
International insurance subsidiary | (54.7 | ) | (16.7 | ) | 7.7 | 22.6 | ||||||||||
Statutory capital and surplus | $ | (55.2 | ) | $ | (10.1 | ) | $ | 139.5 | $ | 92.2 | ||||||
Securities and Exchange Commission registration fee | $ | 183,510.65 | ||
Accounting fees and expenses | $ | 35,000.00 | ||
Legal fees and expenses | $ | 75,000.00 | ||
Financial printing and miscellaneous expenses | $ | 115,000.00 | ||
Total | $ | 408,510.65 |
• | On October 7, 2020, RTPZ issued an aggregate of 5,750,000 RTPZ Class B ordinary shares to the Sponsor for an aggregate gross proceeds of $25,000; |
• | On November 23, 2020, RTPZ issued 4,400,000 warrants to purchase an equivalent number of RTPZ Class A ordinary shares to the Sponsor for aggregate gross proceeds of $6,600,000; and |
• | On August 2, 2021, Hippo Holdings issued 55,000,000 shares of Hippo Holdings common stock to certain qualified institutional buyers and accredited investors that agreed to purchase such shares in connection with the Business Combination for aggregate gross proceeds of $550,000,000. |
† | Certain schedules and exhibits to this Exhibit have been omitted pursuant to Item 601(a)(5) or Item 601(b)(10)(iv), as applicable, of Regulation S-K. The Registrant agrees to furnish supplemental copies of all omitted exhibits and schedules to the SEC upon its request. |
# | Indicates a management contract or compensatory plan. |
* | Previously filed. |
HIPPO HOLDINGS INC. | ||
By: | /s/ Assaf Wand | |
Name: Assaf Wand Title: Chief Executive Officer |
Signature | Title | Date | ||
/s/ Assaf Wand | ||||
Assaf Wand | Director, Co-Founder and Chief Executive Officer(Principal Executive Officer) | April 19, 2022 | ||
/s/ Stewart Ellis | ||||
Stewart Ellis | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | April 19, 2022 | ||
* | ||||
Amy Errett | Director | April 19, 2022 | ||
* | ||||
Eric Feder | Director | April 19, 2022 | ||
* | ||||
Lori Dickerson Fouché | Director | April 19, 2022 | ||
* | ||||
Hugh R. Frater | Director | April 19, 2022 | ||
* | ||||
Noah Knauf | Director | April 19, 2022 | ||
* | ||||
Sam Landman | Director | April 19, 2022 | ||
* | ||||
Sandra Wijnberg | Director | April 19, 2022 |
*By | /s/ Stewart Ellis | April 19, 2022 | ||||
Stewart Ellis | ||||||
Attorney-in-fact |